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Obesity among women is a public health problem in the United States. Pregnancy 
may be one of the causes of this, with 56% of women of childbearing age being 
overweight or obese. Excessive weight gain during pregnancy and postpartum weight 
retention may increase a woman’s risk of obesity and chronic disease later in life. 
Moderate calorie restriction and exercise interventions have been shown to reduce body 
weight and improve body composition during the postpartum period. While weight loss 
interventions have been successful, high attrition rates limit the widespread effectiveness 
of these interventions. Furthermore, there is a lack of research examining the effects of a 
weight loss program on cardiometabolic risk factors in this population. Therefore, the 
primary aim of the studies in this dissertation were: 1) To determine the effect of a diet 
and exercise intervention on weight, body composition, and cardiometabolic risk factors, 
2) to improve lifestyle behaviors through improved diet quality and cardiovascular 
fitness, and 3) to describe the relationship between chronic inflammation and bone 
mineral density (BMD) in overweight and obese postpartum women.  
The first study concluded that a home-based diet and exercise program resulted in 
greater reductions in weight, waist circumference, sagittal diameter, and abdominal fat 
mass compared to a control group. Additionally, the intervention resulted in a significant 
improvement in cardiovascular fitness. The second study concluded that the intervention 
improved triglyceride concentrations, decreased insulin resistance, and improved 
metabolic syndrome risk factors. Finally, the third study concluded that the intervention 
resulted in less loss of BMD at the total body and hip and less loss of BMC at the hip, 
lumbar spine, and femoral neck after controlling for lactation status and weeks 
postpartum at baseline. Change in cardiovascular fitness was a predictor of change in 
total hip and femoral neck BMD, while change in inflammation was a predictor of 
change in total body BMD.  
These results suggest that a home-based, diet and exercise intervention is effective 
in improving body composition, cardiovascular fitness, and some cardiometabolic risk 
factors in overweight and obese postpartum women. Additionally, moderate aerobic 
activity may attenuate bone loss during a weight loss program. 
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CHAPTER I 
INTRODUCTION 
Excessive weight gain during pregnancy and postpartum weight retention increase 
a woman’s risk of obesity later in life. When compared with other age groups, women 
during the childbearing years have demonstrated the greatest increase in obesity 
prevalence in the past 10 years (1). Women who retain some pregnancy weight are more 
likely to weigh more later in life compared to women who lose all of their pregnancy 
weight (2). This is important because obesity is related to the development of metabolic 
syndrome (MetSyn), which is categorized by abdominal obesity, impaired lipids, and 
elevated glucose and blood pressure (3).  It is also associated with increased systemic 
inflammation (4). Together, MetSyn and inflammation increase the risk of chronic 
disease. Postpartum women are at risk of MetSyn due to increased weight retention and 
metabolic changes that occur during pregnancy (5). Increased inflammation may also 
impact bone mineral density (BMD), particularly in breastfeeding women (6). While 
weight loss interventions have been successful in postpartum women, high attrition rates 
and labor-intensive strategies limit the widespread effectiveness of these interventions. 
Furthermore, there is limited research examining the effects of a weight loss program on 
cardiometabolic risk factors in this population. Finally, the relationship between changes.
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in inflammation, body composition, and aerobic exercise with BMD as a result of a 
weight loss intervention has not been examined in postpartum women 
The long-term goal of this research is to determine strategies that will effectively 
reduce postpartum weight retention and prevent obesity among women in order to 
improve health outcomes later in life. The objective of the first study was to determine 
the effects of a diet and exercise intervention on weight loss and body composition in 
postpartum women. The objective of the second study was to determine the effect of this 
intervention on MetSyn, cardiometabolic risk factors, and inflammation in postpartum 
women. The objective of the third study was to examine the relationship between changes 
in inflammation, body composition, and cardiovascular fitness to changes in BMD after 
weight loss.  
In order to test these objectives, we addressed three specific aims: 
1. Determine changes in healthy behaviors as a result of a weight loss intervention 
• Hypothesis: Women in the intervention group would have greater reductions in 
energy intake, greater improvements in diet quality (Healthy Eating Index score), and 
cardiovascular fitness (predicted VO2max) than the control group. 
2. Determine the effect of a 12-week nutrition and physical activity intervention on 
weight, body composition, and cardiometabolic risk factors in postpartum 
women.  
• Hypothesis 1: Women in the intervention group would lose more weight and fat 
mass than those in the control group.  
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• Hypothesis 2: Women in the intervention group would experience greater 
reductions in blood lipids, inflammatory markers (C-reactive protein), glucose, 
insulin, blood pressure, and waist circumference than the control group. 
3. Determine the effect of the intervention on BMD and the association between 
inflammation, body composition, and cardiovascular fitness and BMD. 
• Hypothesis 1: Women in the intervention group would lose less BMD compared 
to women in the control group controlling for breastfeeding status.  
• Hypothesis 2: Women with higher levels of inflammatory markers would have 
lower bone mineral density (BMD) compared to women with lower levels of 
inflammatory markers.  
• Hypothesis 3: Women with the greatest improvements in cardiovascular fitness 
would have less loss of BMD compared to women with decreases in fitness level.  
This research presents the results of a 12-week, home-based diet and exercise 
program, utilizing time and labor-saving strategies, such as individualized diet and 
exercise recommendations, self-monitoring, and regular follow up with a registered 
dietitian (RD) by phone or email. Additionally, it describes the changes in 
cardiometabolic risk factors and inflammation. Finally, it is the first study to our 
knowledge to describe the relationship between inflammation and BMD during weight 
loss in postpartum women.
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
Effect of Diet and Exercise Interventions on Weight and Body Composition in 
Postpartum Women 
According to the 2009-2010 National Health and Nutrition Examination Survey, 
23.9% of women between the ages of 20 and 39 years were overweight, and 31.9% were 
obese (1). Excessive weight retention during the postpartum period may be a contributing 
factor to the development of obesity in this population (2). Postpartum weight retention 
varies greatly among women, and although most women retain just 0.5 to 3 kg 
postpartum (3), approximately 14 to 20% of women retain 5 kg or more at 6 months 
postpartum (4). Women who gained the recommended amount of weight during 
pregnancy weighed 6.5 kg more at a 10 year follow up, while women who gained above 
the recommendation gained 8.4 kg (2). Women who lost all of their pregnancy weight by 
6 months postpartum gained 2.4 kg 10 years later compared to 8.3 kg for those who 
retained some pregnancy weight (2). Interventions targeted toward weight loss during the 
postpartum period may play a role in promoting long-term weight management in women 
of child-bearing age. To date, there have been few randomized controlled trials of weight 
loss interventions in postpartum women. A recent review of the literature found that 
interventions focusing on diet alone and diet plus exercise were equally successful in 
reducing postpartum weight retention (5). The first randomized weight loss trial in this 
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population was conducted by Leermakers et al (6). Ninety postpartum women who had 
retained at least 6.8 kg after pregnancy were recruited between 3 to 12 months 
postpartum. The intervention was a behavioral weight loss program via correspondence 
over six months, which emphasized nutrition, physical activity, and behavior change 
strategies. The participants attended two group sessions, received 16 lessons by mail, and 
were contacted regularly by phone. Women in the treatment group lost significantly more 
weight than women in the control group (7.8 kg vs. 4.9 kg; p < 0.03, respectively). 
Additionally, 33% of the women in the correspondence group returned to their pre-
pregnancy weight compared to 11.5% of women in the control group (p < 0.05). These 
results suggest that a correspondence-based intervention is effective in reducing 
postpartum weight retention. However, this study observed a high attrition rate of 27%.  
Lovelady et al examined the effect of weight loss in 48 overweight, fully 
breastfeeding women on the growth of their infants (7). Women randomized to the 
intervention group were instructed to reduce calorie intake by 500 kcal/day and exercise 
45 minutes four days a week for 10 weeks to achieve a weight loss of 0.5 to 1.0 kg per 
week. Women in the intervention group lost significantly more weight than the control 
group (4.8 kg vs. 0.8 kg). There were no differences in weight or length of the infants. 
This study suggests that modest weight loss of 0.5 kg per week in overweight, fully 
breastfeeding women is safe for the growth of their infants.  
Another study by Kinnunen et al examined the efficacy of a weight loss 
intervention targeting postpartum women at primary health clinics (8). Ninety-two 
primiparas were recruited from 6 child health clinics in Finland. Intervention participants 
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received individual dietary and physical activity counseling at the child’s 2, 3, 5, 6, and 
10 month visits. Dietary counseling focused on four strategies to reduce weight retention: 
having a regular meal plan, consuming at least five servings of fruits and vegetables, 
increasing consumption of high fiber breads, and limiting high sugar snacks to less than 
one portion/day. As a result of the intervention, 50% of the women in the intervention 
group and 30% of the control group returned to pre-pregnancy weight by 10 months 
postpartum, but these results were not significant (p =0.06). These results suggest that 
regular diet and physical activity counseling at primary health care visits is successful in 
reducing postpartum weight retention. However, the dietary changes recommended in the 
intervention may not have adequately reduced caloric intake. Energy intake was not 
reported. 
O’Toole et al studied the effects of a structured diet and exercise intervention on 
postpartum weight retention (9). Forty overweight women between 6 weeks and 6 
months postpartum, who gained more than 15 kg during pregnancy and had retained 
more than 5 kg of weight after delivery were randomly assigned to a structured 
intervention (STR) or a self-directed intervention (SELF). The STR group received 
individual diet and exercise prescriptions, was instructed to keep daily food and activity 
records, and participated in regular group education sessions up to 1 year postpartum. 
Participants in the SELF group met individually with a dietitian and exercise physiologist 
at baseline only. Women in the STR group had a weight loss of 5.6 kg at 12 weeks and 
7.3 kg at 1 year postpartum (p < 0.001). No significant changes in weight were observed 
in the SELF group. While calorie intake was reduced in both groups, there were no 
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significant differences between STR and SELF at any time point. However, energy 
expenditure from physical activity was significantly increased in the STR group, but not 
the SELF group. This study indicates that a structured diet and exercise intervention is 
effective in reducing postpartum weight retention. While both groups reduced energy 
intake, regular contact with mothers was shown to be beneficial in increasing physical 
activity. However, participant retention was low with only 58% of participants remaining 
until 1 year postpartum. 
A larger randomized, controlled weight loss intervention was conducted by 
Ostbye et al (10). A total of 450 overweight and obese women were recruited at 6 weeks 
postpartum. The 9 month intervention consisted of 8 healthy eating classes, 10 exercise 
group classes, and 6 telephone counseling sessions focusing on decreasing intake of total 
calories and calorie-dense foods and increasing fruits, vegetables and physical activity. 
Total weight loss was small overall, with no significant differences between groups. 
Additionally, changes in caloric intake and physical activity did not differ between 
groups. Of note, participation in intervention sessions was low, with participants 
attending an average of 3.8 classes and 3.3 counseling calls. An open-ended survey at the 
completion of the study found that time constraints made it difficult for mothers to attend 
the classes. However, class participation was found to be significantly associated with 
weight loss. These results suggest that while group weight loss classes are successful in 
reducing weight during the postpartum period, the demands of childcare present a burden 
for new mothers to attend classes.  
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 More recently, several studies have been conducted examining the feasibility of 
conducting weight loss interventions in lower income, postpartum women. Craigie et al 
examined the effect of a 12-week individualized diet and exercise intervention in 
overweight women between 6 and 18 months postpartum (n = 52). This study involved 
three face-to-face consultations and three structured phone calls. Participants in the 
intervention group received a personalized diet prescription with a 500 kcal/day deficit 
and a pedometer with instructions to achieve 150 minutes of moderate to vigorous 
activity per week. While this study was not powered to detect change in weight, the 
intervention had small, but significant weight loss of 1.6 kg compared to weight gain in 
the control group of 0.2 kg (11). The attrition rate in this study was 31%. Another study 
conducted by Krummel et al with 151 WIC participants up to 2 years postpartum found 
that facilitated group discussions targeting diet and physical activity changes at WIC 
offices was not successful in reducing weight, and participants in both the self-guided and 
peer-guided groups gained 1.3 kg over one year (12). Participants in this study attended 
an average of 3.6 out of 10 discussion sessions.  
 Physical activity may play a role in promoting weight loss during the postpartum 
period. A recent study examining the impact of a 12 week pedometer-based intervention 
found that breastfeeding women provided with a pedometer and an individualized plan to 
incrementally increase steps to 10,000 daily, resulted in a significant weight loss of 2.1 
kg compared to no weight change in a usual care control group (13). This study also 
found significant reductions in BMI and waist circumference as a result of the study, 
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suggesting that a pedometer-based intervention may be beneficial to improving physical 
activity and promoting weight loss in postpartum women.  
The addition of an energy restriction to an exercise intervention may have 
additional benefits in this population. A study by Davenport et al randomized 40 women 
to one of two walking interventions (30% or 70% of heart rate reserve [HRR]) for 16 
weeks (14). Participants walked three to four days weekly, with at least one supervised 
session per week. Participants also received an individualized nutrition plan designed to 
reduce weight by 0.5 kg/week. Weight loss did not differ between the 30% and 70% 
HRR groups (-5.0 vs. 4.2 kg respectively). However, weight loss was significantly higher 
than the control group. This suggests that an aerobic exercise intervention, combined with 
an energy restriction may be successful in reducing postpartum weight retention.  
Similarly, Colleran et al examined the effects of and energy restriction combined 
with resistance exercise on weight loss in overweight and obese, lactating women (n = 
31) (15). Women were randomized to either the intervention or control groups for 16 
weeks. Women in the intervention group were provided with an individualized diet plan 
and asked to track their diet three days a week online. They were also given a pedometer 
with a goal of walking 10,000 steps daily. Finally, they participated in three supervised 
strength training sessions weekly. Women in the intervention group lost significantly 
more weight than the minimal care control group (-5.8 kg vs. -1.6 kg).  
The most recent study was conducted by Bertz et al. This study aimed to 
determine the effects of diet, exercise, and a combination of the two on weight loss in 
overweight and obese, lactating women (16). Sixty-eight lactating women between 10 
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and 14 weeks postpartum were randomized to one of four groups for 12 weeks: a control 
group, a dietary modification group, an exercise group, and a diet plus exercise group. 
Participants in both the dietary and diet plus exercise groups received 2.5 hours of 
individual counseling. The dietary group was instructed to reduce calories by 500 kcal 
per day using four key steps. They were also given an electronic scale to self-monitor 
weight. The exercise group was instructed to walk 45 minutes four days weekly. The diet 
and exercise group received both treatments and a total of five hours of individualized 
counseling. For analysis, both groups that received the dietary intervention (diet only and 
diet plus exercise) were pooled together. They found a significant effect of diet on weight 
loss (diet only: -8.3 kg, diet plus exercise: -6.9 kg) compared to the control group (-0.8 
kg). This study did not find an effect of exercise or an interactive effect between diet and 
exercise on weight loss in overweight, lactating women. These results suggest that weight 
loss interventions in lactating women should be focused primarily on dietary strategies, 
as the addition of exercise did not impact changes in body composition.   
Randomized controlled trials of weight management interventions in postpartum 
women have demonstrated that programs providing individualized diet and physical 
activity education are successful in reducing body weight among postpartum women. 
Interventions that target dietary interventions alone or combine diet and exercise may be 
successful in reducing weight retention. Additionally, a modest weight loss of 0.5 kg does 
not appear to be detrimental to lactation performance and infant growth. Some of these 
studies are limited by a low rate of participant retention (6, 9, 11), while two others had 
low rates of compliance with group-based interventions (10, 12). Other studies that 
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involved supervised exercise sessions resulted in significant weight loss (14-16). 
However, these types of interventions are labor-intensive, and may not be practical to 
implement on a large scale. This suggests that while the postpartum period may be ideal 
for weight loss interventions, time constraints associated with caring for an infant and 
returning to work may limit a woman’s ability to attend group educational classes, follow 
a diet plan, and exercise regularly. Therefore, it is important to design an intervention that 
is individualized to the participant and reduces the time burden on a woman.  
Effects of Weight Loss on Inflammation 
Overweight and obesity increase the risk of developing chronic disease, including 
cardiovascular disease, type 2 diabetes, and certain types of cancer (17). Elevated 
inflammatory proteins secreted by adipose tissue are responsible for this increased risk 
(18). In 1993, tumor necrosis factor alpha (TNF-α) was found to be secreted by 
adipocytes (19). Since then, over 50 inflammatory proteins have been discovered to be 
produced by adipose tissue, including adiponectin, leptin, C-reactive protein (CRP), and 
interleukins (IL) (20). Obesity is now characterized as a condition of low-grade 
inflammation resulting from increased adipocyte size and quantity (17), with overweight 
and obese individuals having higher plasma concentrations of inflammatory proteins than 
leaner individuals. Since excess adipose tissue is responsible for this increased 
inflammation, previous research has sought to determine if weight loss exerts an anti-
inflammatory effect (18). While the association between obesity and inflammation is well 
defined, the effect of weight loss on these biomarkers in humans remains unclear (21). 
Therefore, it is important to determine if weight loss reduces obesity-induced 
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inflammation in order to develop effective strategies to reduce the incidence of chronic 
disease. 
Several observational studies have examined the association of body weight and 
inflammatory protein levels in humans. One study found that CRP was positively 
associated with weight category (22). Compared to participants in the normal BMI 
category, CRP level increased as BMI category increased. Another study examined the 
effects of body weight and metabolic syndrome on inflammatory biomarkers among post-
menopausal women (23). Participants (n = 1,889) were stratified into four body size 
phenotypes based on weight status (normal weight vs. overweight/obese) and presence of 
metabolic syndrome risk factors or diabetes. Being overweight or obese and having at 
least two metabolic risk factors were independently associated with increased CRP, IL-6, 
and TNF-. However, these risks diminished when adjusted for waist circumference, 
suggesting that while body weight and metabolic syndrome independently increase 
inflammation in post-menopausal women, abdominal obesity is a stronger predictor of 
increased inflammation.   
 These results demonstrate the link between excess body fat, specifically visceral 
fat, and systematic inflammation. From these results, it can be inferred that a reduction in 
body weight will alleviate this response. However, intervention studies in humans have 
found mixed results. Additionally, while several studies have examined the effects of 
weight loss on inflammation, dietary recommendations have varied widely, and there are 
few randomized, controlled trials.  
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Zahorska-Markiewicz et al aimed to determine the effects of a calorie restricted 
diet on TNF-α (24). Twenty-three obese women and 17 lean control women were 
recruited. Obese women were instructed to follow a 1000-1200 kcal diet and exercise 
daily for 3 months. The intervention resulted in a mean weight loss of 11.4 kg and a 
significant decrease in TNF-α in the obese group. Sheu et al (25) conducted a similar 
study with 21 obese women. Ten lean women served as controls. Participants were 
instructed on consuming a diet with a 500 to 1000 kcal/day deficit for 12 weeks. Weight 
loss of 5% body weight was observed. Serum high sensitivity CRP (hs-CRP), TNF-α, and 
IL-6 were significantly higher in the obese group than the lean controls at baseline. 
However, hs-CRP was significantly reduced after the intervention. This study shows that 
obesity is associated with increased inflammatory markers, and moderate calorie 
restriction is adequate to reduce these effects in obese individuals. Finally, Heilbronn et 
al studied the effects of a 1400 kcal, 15% fat diet on inflammation in 83 obese women 
(26). The intervention resulted in a 7.9 kg weight loss, which was associated with a 
reduction in CRP (5.56 mg/L to 4.12 mg/L). This study also found that CRP was 
correlated with degree of weight loss (r = 0.27, p = 0.01).  
The previous studies demonstrate that dietary changes have an impact on 
inflammatory markers. Fisher et al (27) aimed to determine if exercise exhibits this same 
effect. Overweight, premenopausal women (n = 213) were randomized to either a diet 
only, diet plus aerobic exercise, or diet plus resistance exercise group in order to 
determine the differential effects of two types of exercise on inflammatory markers. An 
800 kcal very low calorie diet (VLCD) was provided for participants until they reached a 
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BMI less than 25 kg/m2. IL-6 was reduced only in the diet plus resistance exercise group, 
while CRP decreased in the diet only and diet plus resistance exercise group. 
Additionally, all markers were associated with total and abdominal fat, which explains 
differences among groups. This study shows that a VLCD only and combined with 
resistance exercise result in reductions in some inflammatory markers. However, these 
results are likely related to changes in body fat composition and distribution rather than 
the type of exercise.  
Another randomized study examined the independent and joint effects of calorie-
restriction and exercise on inflammatory and metabolic markers (28). Participants (n=79) 
were obese, physically inactive men and women and were randomized to one of three 
interventions for 8 weeks: exercise only (EXO), VLCD diet only (DIO), and VLCD plus 
exercise (DEX). The EXO group lost 3.5% body weight, while the DIO and DEX groups 
lost 10.5% and 11.1% respectively. Inflammatory markers were not changed in the EXO 
group. However, both the DIO and DEX groups experienced significant and similar 
reductions in IL-18 and IL-15. IL-6 was only reduced in the DEX group, while 
adiponectin was significantly increased in DIO and DEX. Weight loss with both calorie 
restriction and exercise induced a reduction in inflammatory proteins in obese individuals 
with diet plus exercise leading to greater changes in IL-6. This study suggests weight 
loss, regardless of the method, is responsible for changes in inflammatory markers. 
To date, only two randomized, controlled trials have been conducted examining 
the effect of a moderate energy restriction on inflammation. Nicklas et al randomized 316 
obese, older adults to receive either a normal diet or behavioral counseling to achieve and 
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maintain a 5% weight loss over 18 months (29). This study found that the intervention 
group was successful in reducing weight by 5.1% compared to 1.8% in the control group. 
CRP was reduced by 3%, while IL-6 was reduced by 11% in the intervention group. 
Another study randomized 120 obese women to either a normal diet or a 1300-1500 kcal 
Mediterranean-style diet for two years (30). The intervention group had a weight loss of 
14.7% compared to 3.2% in the control group. CRP was reduced by 34% and IL-6 
reduced by 33% in the intervention group compared to no changes in the control group.  
The degree of weight loss may play a role in reducing inflammation, with greater 
changes in weight necessary to observe a significant reduction in inflammatory proteins. 
A systematic review compared the results of weight loss interventions, and found that for 
every 1 kg weight lost, there was a 0.13 mg/L decline in CRP (31). However, Madsen et 
al found that weight loss greater than 10% may be necessary to induce changes in CRP 
(32).  
The current literature investigating the effects of calorie restriction on 
inflammation has produced conflicting results. Variations in dietary intervention, 
duration, inflammatory markers measured, and degree of weight loss make it difficult to 
assess which interventions have a positive effect on inflammation. Additionally, many 
studies utilize a VLCD to induce weight loss. While this diet is successful in inducing 
substantial weight loss, it is not a realistic diet to follow in the long term. There is a need 
for randomized, controlled trials comparing the effects of a modest energy-restriction diet 
on weight loss and inflammation. Finally, the effect of weight loss on inflammation in 
postpartum women is unclear.  
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Pregnancy is also associated with elevated inflammatory cytokines, specifically, 
CRP. However, there is a large variation in patterns of change among studies. Some 
studies suggest that CRP increases gradually over the duration of pregnancy (33, 34). 
Others found that CRP is elevated in early pregnancy and remains elevated throughout 
gestation (35) or peaks during the second trimester (36). Variations in CRP 
concentrations may be related to pre-pregnancy BMI and gestational weight gain. 
However, few studies have examined this relationship during the postpartum period. 
Inflammation may remain high during the early postpartum period due to the 
immunologic stress of delivery (27). Kuzawa et al compared CRP level in women during 
various stages of the reproductive cycle (34). Compared to nulliparous women (0.2 
mg/L), women during the second (1.5 mg/L) and third trimester (2.0 mg/L) had higher 
CRP levels. CRP was decreased in women during the first year postpartum. Women who 
breastfed tended to have lower CRP levels than women who formula fed, but this 
difference was not significant. However, sample size was small and variability was large 
in the population studied. In contrast, Groer et al found that exclusively breastfeeding 
women tend to have a higher pro-inflammatory response in the first 4 to 6 weeks after 
delivery than formula feeding women (38).  However, a longitudinal study conducted 
over 5 months postpartum found no significant differences in CRP between breast and 
formula feeders (39). CRP was significantly associated with BMI, which may explain 
why no differences were observed. 
Excessive weight gain during pregnancy and obesity during the postpartum period 
may exacerbate elevations in CRP, and weight loss may improve inflammation in these 
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women. However, few studies have examined the impact of weight loss on inflammation 
in postpartum women. A study of 129 overweight and obese postpartum women between 
2 weeks and 6 months postpartum compared the effects of an energy-restricted 
Mediterranean diet to a USDA MyPyramid diet on weight loss and inflammation (40). 
Both groups lost a similar amount of weight and had similar reductions in TNF-α over the 
4 month intervention. However, there were no differences between dietary interventions. 
This study did not have a control group, so it is unclear whether these results are due to 
weight loss or normal reductions that occur during the postpartum period.  
Another study randomly assigned 68 fully breastfeeding women with a BMI > 25 
kg/m2 to one of four groups for 12 weeks: control, diet only, exercise only, diet plus 
exercise (41). While both diet intervention groups lost significantly more weight than the 
control and exercise only groups, there were no significant changes in CRP, TNF-α, or 
IL-6. This may be related to large variations in concentrations of these inflammatory 
markers or the natural immunologic changes that occur after delivery. The current studies 
are of relatively short duration. Studies examining longer duration weight loss 
interventions may yield greater changes in inflammation. Also, the role lactation plays in 
altering inflammation during weight loss in postpartum women remains unclear.  
Effects of Weight Loss on Metabolic Syndrome 
Metabolic syndrome (MetSyn) is a cluster of symptoms that have been shown to 
increase the risk of cardiovascular disease and type 2 diabetes (42). The National 
Cholesterol Education Program III defines MetSyn in women as (1) abdominal obesity 
greater than 80 cm, (2) triglycerides greater than 150 mg/dL, (3) HDL cholesterol less 
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than 50 mg/dL, (4) blood pressure greater than 130/85 mm Hg, and (5) fasting glucose 
greater than 100 mg/dL (43). A diagnosis is made if 3 or more of the above criteria are 
met. In the United States, 21.8% of women meet the criteria for MetSyn (44). 
Furthermore, MetSyn is associated with systemic inflammation. A study by Ridker et al 
found that CRP levels increased as the number of MetSyn characteristics increased, with 
CRP of 3.01 mg/L associated with a diagnosis of MetSyn (45).  
 Childbearing has been shown to increase a woman’s risk of developing MetSyn 
later in life. Gunderson et al found that compared to nulliparous women, the risk of 
developing MetSyn was 1.33 times higher in woman who gave birth once and 1.62 times 
higher in women who gave birth at least two times during the 20 year follow-up (46).  In 
addition to this, women who are overweight or obese during the postpartum period may 
be at increased risk of MetSyn. A recent study compared the prevalence of MetSyn in 
overweight and obese, fully breastfeeding women (47). Of the 68 participants in this 
study, 6.2% were classified as having the metabolic syndrome, meeting the criteria with 
high waist circumference and blood pressure and low HDL cholesterol. Additionally, 
obese women had higher waist circumference, fasting insulin, and triglycerides compared 
to overweight women.  
Lactation may protect women against development of MetSyn by lowering risk 
factors in the postpartum period. Cholesterol and triglycerides are elevated during 
pregnancy, but decline during the postpartum period (48). A study by Darmady and 
Postle found that triglyceride levels fell to baseline 13 weeks earlier in breastfeeding 
women compared to formula feeding women (49). Another study found that HDL levels 
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were higher in lactating women (50). This reduction in lipids is likely due to secretion 
into breast milk. During lactation, physiologic changes result in the secretion of 10 to 20 
mg/L of cholesterol and 3.5 to 4.6 g/L of triglycerides into breast milk (51). HDL levels 
remain elevated due to increased VLDL transport during lactation (52). 
 Lactation has also been shown to reduce insulin resistance and improve glucose 
homeostasis in women with and without gestational diabetes. Kjo et al examined 809 
postpartum women with recent gestational diabetes and found that area under the glucose 
tolerance curve was significantly lower in lactating women compared to non-lactating 
women (50). Fasting glucose and 2-hour postprandial glucose levels were lower in 
breastfeeding women. Another study among healthy postpartum women found that 
insulin resistance as measured by insulin-glucose ratio was lower in lactating compared 
to non-lactating women at 3 months (10 ± 5 vs. 15 ± 5) and at 6 months postpartum (12 ± 
6 vs. 15 ± 5) (53). The reason for improved blood glucose and insulin sensitivity is that 
glucose is used as a precursor for lactose and lipids, with increased glucose utilization 
and insulin sensitivity in mammary tissue (54). 
In addition to reducing risk factors during the postpartum period, breastfeeding 
may also reduce the risk of developing MetSyn later in life. A cross-sectional study by 
Ram et al examined the association between lactation and MetSyn among women in 
midlife (55). This study found that the duration of lactation was inversely correlated with 
systolic and diastolic blood pressure, fasting glucose, triglycerides, total cholesterol, and 
LDL cholesterol, and positively correlated with HDL cholesterol. Additionally, duration 
of breastfeeding was associated with a reduced risk of developing MetSyn in midlife with 
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an OR for each year of lactation of 0.88 (95% CI: 0.77, 0.99). These studies suggest that 
lactation may protect against dyslipidemia and insulin resistance during the postpartum 
period, which reduces the risk of developing MetSyn during midlife. 
 Studies that examine the effect of a weight loss intervention on MetSyn are few, 
focus on manipulations of dietary macronutrients, and lack a usual care control group. A 
study by Noakes et al of 100 obese women compared the effects a 12-week dietary 
intervention using either an energy restricted, high-protein, low-fat diet or an isocaloric 
high-carbohydrate, low-fat diet on cardiovascular risk factors (56). Both groups lost 7.3 
kg, with similar changes in HDL and LDL cholesterol, glucose, and insulin. However, 
TG decreased significantly more in the high protein group compared to the high 
carbohydrate group (-0.30 vs. -0.11 mmol/L). Another study examined the effect of an 
energy restricted, high protein diet with and without exercise on MetSyn (57). 
Overweight and obese women (n = 44) were randomized to either a control diet (1:3 
protein to carbohydrate), control diet plus exercise, high protein diet (1:1 protein to 
carbohydrate), or a high protein diet plus exercise group for 12 weeks. Weight loss was 
greatest in the high protein with exercise group, while reductions in total cholesterol were 
greatest in the control plus exercise and high protein groups. A significant reduction in 
triglycerides was observed only in the high protein plus exercise group. These studies 
suggest that while a high protein diet may be beneficial for improving triglycerides, 
changes in other MetSyn criteria may be more dependent on weight loss.  
 Another study examined the effect of aerobic exercise on cardiovascular risk 
factors during a weight loss intervention (58). Seventy-seven overweight and obese post-
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menopausal women were randomized to either a weight loss alone or weight loss plus 
aerobic exercise intervention for six months. Both groups had similar reductions in 
weight, waist circumference, systolic blood pressure, triglycerides, insulin, and insulin 
resistance. However, the exercise group had significantly greater increases in HDL 
cholesterol, suggesting that the addition of exercise to a weight loss intervention may 
help reduce the risk of MetSyn.  
There have been several studies examining the effects of diet and exercise 
interventions on cardiovascular risk factors in postpartum women. The first study by 
Lovelady et al randomized 33 fully breastfeeding women between 6 to 8 weeks 
postpartum to either an exercise or a control group for 12 weeks (60). The exercise 
intervention consisted of 45 minutes of supervised aerobic exercise 5 days weekly. There 
were no differences between groups for total cholesterol, LDL, triglycerides, and insulin 
and glucose response to a test meal. There was a trend for an increase in HDL in the 
exercise group, but this was not significant. However, weight loss was the same for both 
groups. Another study examining the effects of an exercise intervention (50-60 minutes 
of supervised aerobic exercise 3 days per week) on cardiovascular risk factors in lactating 
women 4 to 6 weeks postpartum found no significant differences between groups for 
weight loss or lipid concentrations (61). Women in both of these studies were normal 
weight, which may have limited the effectiveness of the interventions.  
 Interventions that combine an energy restriction with exercise have observed 
greater changes in MetSyn risk factors. Davenport et al randomized 40 overweight and 
obese women who were 7 to 8 weeks postpartum to one of two exercise groups, with an 
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additional 20 women in a control group (14). Women in the intervention groups walked 
45 minutes/day on 3 to 4 days/week at either 30% or 70% of heart rate reserve (HRR) for 
16 weeks. They were also given individualized dietary recommendations in order to 
reduce weight by 0.5 kg/week. Both groups had significant reductions in weight (30%: -
4.2 kg, 70%: -5.0 kg), waist circumference, glucose, and LDL cholesterol compared to 
the control group. However, differences between groups were not significant.  
 Recently, Brekke et al examined the effect of diet alone, exercise alone, or diet 
plus exercise on weight loss and cardiovascular risk factors in 68 overweight, lactating 
women between 10 and 14 weeks postpartum (41). Women in the diet and diet plus 
exercise groups lost significantly more weight compared to the control or exercise alone 
groups. Additionally, the two diet groups had significantly greater reductions in waist 
circumference, total cholesterol, LDL, and insulin after the 12 week intervention. These 
studies suggest that a diet and exercise intervention is necessary to achieve the weight 
loss needed to reduce MetSyn risk factors in postpartum women.  
 While childbearing is associated with an increased risk of MetSyn (46), lactation 
may reduce risk factors that contribute to development of MetSyn and chronic disease. 
Research on the impact of diet and exercise interventions on risk factor in overweight and 
obese, postpartum women are conflicted. However, previous studies suggest that physical 
activity, in addition to an energy restriction diet may be beneficial in reducing weight and 
improving MetSyn risk factors.  
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Effect of Systemic Inflammation on Bone Mineral Density 
While obesity has been shown to be associated with elevated bone mineral density 
(BMD) and protective against bone loss, (61) obese individuals exhibit elevated levels of 
inflammatory cytokines, such as IL-6, TNF-α, and CRP. These cytokines are also 
involved in bone remodeling. Bone mass undergoes continuous remodeling during 
adulthood. In typical bone remodeling, osteoclasts adhere to the bone, and dissolve old 
bone. Then, osteoblasts attach to the resorbed bone, promoting the deposition of osteoid, 
which mineralizes into new bone tissue (62). Thus, bone mass is maintained by a balance 
between osteoclast and osteoblast activity. When this balance is interrupted, bone loss 
will occur. IL-6 has been shown to be involved in maintaining this balance. It is produced 
by stromal-osteoblastic precursor cells and acts to stimulate osteoclastogenesis and bone 
resorption (63). This production is stimulated by IL-1 and TNF-α. Lactation is associated 
with a decrease in BMD, with peak bone loss of 1 to 3% per month (64). After weaning, 
BMD rapidly returns to baseline levels (65). However, it is unclear if inflammation 
associated with obesity exacerbates this bone loss or inhibits the gains observed after 
weaning.  
 There have been several studies that have examined the relationship between low-
grade systemic inflammation and BMD in postmenopausal women with conflicting 
results. Scheidt-Nave et al examined 89 overweight postmenopausal women and found 
that serum IL-6 was predictive of femoral bone loss, adjusted for menopausal age, BMI, 
serum PTH, and other factors (66). This effect was most prominent during the first 10 
years after menopause. Gertz et al examined the relationship between various 
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inflammatory markers and change in BMD over one year in 235 postmenopausal women. 
IL-6 and TNF-α were significantly associated with BMD at the hip, lumbar spine, 
femoral neck, trochanter, whole body, and distal tibia (67). In a regression analysis, a 
combination of inflammatory markers (IL-6, TNF-α, IL-1β, and CRP) contributed to 
change in hip, lumbar spine, trochanter, and whole body BMD, while CRP contributes to 
change in lumbar spine, whole body, and trochanter BMD, and TNF-α and IL-6 
contribute to change in hip BMD. Ding et al found that hs-CRP at baseline and change in 
hs-CRP were associated with change in total body BMD in older men and women (68). 
Additionally, baseline IL-6 and change in IL-6 were associated with change in total body 
and spine BMD.  Quartiles of TNF-α were associated with change in total body and spine 
BMD. Finally, Papadopoulous et al found that BMD at various sites (lumbar spine, 
femoral neck, Ward’s triangle, shaft, radius, and ultradistal were negatively correlated 
with IL-6 (69). 
However, several studies found no significant association between inflammatory 
markers and BMD. Kania et al found that there was no correlation between IL-6 and 
BMD at the lumbar spine or femoral neck in postmenopausal women (70). Similarly, 
Ganesan et al found that CRP was not associated with BMD when controlling for 
confounders that may also impact BMD, including age, ethnicity, BMI, hormonal 
replacement therapy use, and immobility (71).  
 Koh et al studied the relationship between hs-CRP and bone mineral density in 
pre- and postmenopausal women. CRP levels were significantly higher in women with 
osteoporosis and osteopenia (72). Further, the highest quintile of hs-CRP was associated 
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with significantly lower femoral neck BMD compared to the lowest quintile. The 
relationship was observed in both pre- and postmenopausal women. However, this 
population was within a normal BMI range and CRP levels were low, with 0.7 and 1.0 
mg/L in pre- and postmenopausal women respectively. 
 Salamone et al aimed to determine this relationship in 50 premenopausal women.  
TNF-α was modestly correlated with femoral neck BMD (r = -0.30, p < 0.05) (73). 
Additionally, women in the 75th percentile of IL-6 and TNF-α had lower lumbar spine 
BMD (0.963 ± 0.18 g/cm2) than women with lower levels of these proteins (1.08 ± 0.07 
g/cm2). Finally, the annual rate of bone loss at the lumbar spine tended to be greater in 
women with higher IL-6, but this was not significant.  
 Finally, De Pablo et al examined data from the NHANES survey to determine the 
relationship between CRP and BMD (74). Men and women (n = 10,475) with ages 
ranging from 20 to 85 years were studied. They found a significant inverse, dose-
dependent association between CRP and total body and lumbar spine BMD among 
women. In this study, average BMI for women was 28.7 kg/m2, with a median CRP of 
1.29 mg/dL.  
Two studies in premenopausal women did not find a significant association 
between inflammation and BMD. Jeon et al studied the relationship between BMD and 
metabolic syndrome in 2,165 pre- and postmenopausal women (75). This study found 
that premenopausal women with metabolic syndrome had lower BMD at the lumbar 
spine after adjusting for age, height, weight, CRP and other covariates, while 
postmenopausal women had lower lumbar spine and femoral neck BMD compared to 
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women without metabolic syndrome. CRP was found to be a significant predictor of 
femoral neck BMD in postmenopausal, but not premenopausal women, with higher CRP 
associated with lower BMD (β = -0.064, p = 0.001). Hwang et al examined 2,558 women 
18 years and older to compare the relationship between metabolic syndrome and CRP 
with BMD. They found that women with abdominal obesity and hypertriglyceridemia 
had significantly lower vertebral BMD (76). Also, vertebral BMD was lower in women 
with metabolic syndrome (0.858 ± 0.007 g/cm2) compared to women without (0.925 ± 
0.004 g/cm2). However, CRP was not significantly correlated with BMD.  
Studies examining the relationship between inflammation and BMD are 
conflicting. IL-6, TNF-α, and CRP may be associated with loss of BMD in older adults, 
with higher levels of inflammation predicting reduced BMD. However, this same 
relationship is less clear in premenopausal women, who are at a lower risk of bone loss 
and osteoporosis. Women with the metabolic syndrome may be at an increased risk of 
bone loss due to increased inflammation.   
Effect of Weight Loss on Bone Mineral Density 
Weight loss is a desirable outcome for overweight and obese individuals, as it 
may decrease systemic inflammation. However, modest weight loss has been shown to 
increase bone turnover and decrease BMD, particularly at the hip and lumbar spine. 
Several studies have examined this relationship and found that small weight loss in 
overweight and obese women over 3 to 18 months resulted in small, but significant 
reduction of BMD at the total body (77, 78), lumbar spine (77), and hip (79).  
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Exercise may help attenuate this loss of BMD. In a study by Fogelholm et al, 82 
obese, premenopausal women followed a very low energy, weight reduction diet for 3 
months (80). After the weight loss phase, they were randomized to either a control group 
or one of two exercise groups consisting of walking in order to expend 1,000 or 2,000 
kcal/week for 9 months. Weight loss of 14.3% after the first three months resulted in a 
significant decrease in total body, spine, and femoral neck BMD. After 9 months of 
exercise, there was a significant decrease in BMC, but no changes in BMD in both 
exercise groups. However, differences between groups were not significant. Similarly, a 
study by Rector et al randomized 36 overweight and obese premenopausal women to one 
of three groups in order to induce a 5% weight loss: energy restriction only, energy 
restriction plus nonweight-bearing exercise (cycling), and energy restriction plus weight-
bearing exercise (treadmill running) (81). This study found that while markers of bone 
turnover, osteocalcin and C-terminal telopeptide of type I collagen, were significantly 
increased, there was no difference between groups. These studies suggest that aerobic 
exercise may not be adequate to prevent weight-loss induced changes in BMD in 
premenopausal women.  
Due to its impact on bone health, resistance training may reduce the bone loss 
observed with weight loss. A study by Nakata at al examined this relationship in 43 
overweight, premenopausal women (82). Participants were randomized to one of two 
groups. The diet only group consisted of a 1,200 kcal/day dietary restriction, while the 
diet plus resistance training incorporated three 90 minute resistance training sessions per 
week for 14 weeks. While there was a significant reduction in total body BMD, no 
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significant differences were observed between groups. However, the resistance exercise 
group lost significantly more weight and fat mass, which may have contributed to these 
results.  
Resistance exercise may also be beneficial to BMD during lactation. Lovelady et 
al randomized 20 fully breastfeeding women at 4 weeks postpartum to either the exercise 
or control group (83). Women in the exercise group participated in weight-bearing 
aerobic exercise and resistance training 3 days/week. The exercise group lost less lumbar 
spine BMD compared to the control group, despite similar weight loss. Another study by 
Colleran et al aimed to determine if resistance exercise would slow bone loss during 
weight loss in overweight, fully breastfeeding women (15). Thirty-one women were 
randomly assigned to either the minimal care group or the intervention group for 16 
weeks. The intervention group was prescribed a 500 kcal/day deficit, asked to walk at 
least 10,000 steps daily, and participated in supervised resistance training sessions 3 days 
weekly, targeting core strength. Total body, lumbar spine, and total hip BMD decreased 
significantly over time, but there were no differences between groups. However, the 
intervention group lost significantly more weight than the minimal care group, suggesting 
that resistance exercise is protective against increased bone loss in lactating women 
during weight loss.  
Calcium intake during weight loss may also be protective against bone loss during 
diet-induced weight loss. Shapses et al examined 60 obese, premenopausal women, and 
randomly assigned them to receive either a 1,000 mg calcium supplement or placebo 
during the 6 month weight loss study (84). They found that moderate energy restriction 
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yielding at least 5% weight loss in both groups did not significantly alter total body BMD 
or BMC. However, BMD at the lumbar spine significantly increased in the calcium 
group, compared to a decrease in the placebo group, suggesting that adequate calcium 
during weight loss can prevent bone loss. Similarly, Riedt et al found that there was no 
change in BMD with moderate weight loss at either high (1.8 g calcium/day) or adequate 
(1.0 g calcium/day) calcium intakes (85). There was an increase in BMD at the one-third 
radius, and a trend for an increase in femoral neck BMD with the high calcium group.  
The mediating effect of systemic inflammation on BMD during weight loss is not 
well understood. A study by Silverman et al in 86 overweight and obese postmenopausal 
women examined the effect of aerobic exercise in combination with moderate weight loss 
on circulating inflammatory proteins in order to determine its impact on BMD (86). 
Subjects were randomized to either a moderate energy restricted diet or an energy 
restriction plus walking for 45 to 60 minutes three days weekly. This study found that 
femoral neck BMD was increased in the exercise group compared to diet alone. 
Additionally, change in femoral neck BMD was negatively correlated with change in 
TNF-α receptor 1. However, there was no correlation between other inflammatory 
proteins. Change in femoral neck BMD was positively correlated with change in VO2 
max, while VO2 max was negatively associated with change in sIL-6 receptor, suggesting 
a possible mediating relationship between aerobic exercise, BMD, and inflammation.  
A recent study in 51 overweight and obese premenopausal women was conducted 
to determine if adequate dairy consumption attenuates the loss of BMD during a weight 
loss intervention and to determine the association between inflammatory markers and 
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BMD (87).  The dietary intervention was designed to achieve an energy reduction of 500 
kcal/day. Participants were randomized to either an adequate or low dairy group. This 
study found that lumbar spine BMD was higher in the adequate dairy group (0.5% 
increase vs. 1.4% decrease). Additionally, there was a negative association between 
inflammatory proteins (IL-1β, TNF-α, and CRP) with markers of bone turnover. 
Regression analysis found that post-weight loss inflammatory and endocrine factors 
accounted for 19.6% of the variance in hip BMD.  
 These studies suggest that systemic inflammation may negatively impact BMD by 
stimulating bone resorption. Additionally, weight loss may lead to decreases in BMD. 
However, these relationships are inconsistent across studies. While studies in 
postmenopausal women show a benefit to adding aerobic or resistance exercise to 
moderate energy restriction and maintaining an adequate intake of calcium, these results 
are inconclusive in overweight and obese premenopausal women. Furthermore, the 
relationship between inflammation and BMD during weight loss is not well understood. 
While obesity appears to be protective against bone loss, elevated circulating 
inflammatory proteins may blunt this effect. No studies have looked at this relationship in 
lactating women, who experience reductions in BMD. Elevated inflammation in lactating 
women may exacerbate this bone loss during weight loss.
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CHAPTER III 
EFFECTS OF AN RD-GUIDED DIET AND EXERCISE INTERVENTION ON 
WEIGHT AND BODY COMPOSITION IN POSTPARTUM WOMEN 
 
 
     Formatted for publication in the Journal of the Academy of Nutrition and Dietetics 
Introduction 
Obesity is a public health problem in the United States. According to the 2009-
2010 National Health and Nutrition Examination Survey, 23.9% of women between the 
ages of 20 and 39 years were overweight, and 31.9% were obese (1). Excessive weight 
retention during the postpartum period may be a contributing factor to the development 
of obesity in this population (2). Postpartum weight retention varies greatly among 
women, and although most women retain just 0.5 to 3 kg postpartum (3), approximately 
14 to 20% of women retain 5 kg or more at 6 months postpartum (4). In a long-term 
examination of postpartum weight retention, women who gained the recommended 
amount of weight during pregnancy weighed 6.5 kg more at a 10 year follow up, while 
women who gained above the recommendation weighed 8.4 kg more (2).  In addition, 
women who lost all of their pregnancy weight by 6 months postpartum gained 2.4 kg 10 
years later compared to 8.3 kg for those who retained some pregnancy weight (2). 
Interventions targeted toward weight loss during the postpartum period may play a role in 
promoting long-term weight management in women of child-bearing age.  
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To date, several randomized, controlled trials utilizing individual diet and/or 
exercise counseling for postpartum women have been conducted, showing moderate, 
short-term weight loss (5-9). A more recent study by Bertz et al examined the effects of 
diet, exercise, or a combination on weight loss in postpartum women (10). They found 
that dietary intervention alone was successful in reducing weight, with no additional 
benefits to adding exercise. Furthermore, a study by Lovelady et al found that modest 
weight loss of 0.5 kg/week, through dietary restrictions and aerobic exercise, resulted in 
significant weight loss with no adverse effects on lactation performance and infant 
growth (8). Finally, a recent review of the literature found that interventions combining 
diet and exercise are successful in reducing postpartum weight retention (11). This 
review also found that home-based interventions utilizing technology-based 
correspondence, such as text messages, emails, and phone calls may increase weight loss.  
While these studies show that modest calorie restriction, combined with physical 
activity, may be successful in reducing weight in postpartum women, several other 
studies had high drop-out rates (31% to 42%) (5, 6). Additionally, compliance with an 
intervention may be limited, due to the time constraints associated with caring for an 
infant. This may affect a woman’s ability to follow a diet plan and exercise regularly. 
Several studies utilizing supervised, home-based exercise sessions observed higher 
compliance and significant weight loss (7, 8). However, these are labor-intensive and 
may not be feasible to implement in a larger population. Furthermore, another study that 
required participation in classes was not successful in promoting weight loss due, in part, 
to low participant attendance rates (9). This suggests that time-intensive interventions 
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may not fit into the busy schedules of new mothers. Therefore, there is a need to develop 
a weight loss intervention that does not require class participation or regular, labor-
intensive supervised home visits, but is tailored to the needs of individual participants. 
Thus, the purpose of this study was to determine the effects of a home-based diet and 
exercise intervention, guided by a registered dietitian (RD), on weight and body 
composition in postpartum women.  
Methods 
Study Participants 
Participants were recruited from pre- and postnatal classes and flyers posted in 
obstetrician’s offices and in community settings in Greensboro, NC. Women were 
screened by telephone or email after the birth of their infant. They were eligible if they 
were between 6 to 14 weeks postpartum, had a self-reported BMI between 25 and 35 
kg/m2 or were at least 4.5 kg heavier than self-reported pre-pregnancy weight at the time 
of screening, were 18 years and older, and sedentary (participation in physical activity < 
3 days per week). Participants were excluded if they were smokers, had a multiple-birth, 
or had a preexisting medical condition. Women who had a cesarean section were eligible 
to participate at 14 weeks postpartum. All participants were medically cleared for a diet 
and exercise intervention by their physician. Sample size was determined using the 
results from two previous studies (8, 9). A sample size of 26 (13 per group) was 
estimated to provide 80% power with a two-sided α level of 0.05 to detect a 2.5 kg 
change in weight.  
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Study Design 
Participants were stratified based on pre-pregnancy BMI (BMI <30.0 kg/m2 and 
≥30.0kg/m2) and time from childbirth (< 10 weeks and ≥ 10 weeks). Computer-generated 
block randomization with a block size of 4 was used within each stratum to divide 
participants into either the intervention or control group. Group assignment was 
concealed in individually sealed envelopes by a third party. Participants were randomized 
after all baseline measurements were completed. The study protocol was approved by 
The University of North Carolina at Greensboro Institutional Review Board. It is 
registered with ClinicalTrials.gov (NCT01668316). 
Study Intervention 
Intervention Group. The intervention group participated in a 12-week diet and 
exercise program starting at 6 to 14 weeks postpartum. Participants worked with the RD 
to reduce energy intake and improve diet quality. The intervention focused on 
components of the cognitive behavioral theory (CBT) to facilitate behavior change. 
Briefly, CBT is designed to aid in overcoming psychological barriers to behavior change. 
Components of this behavior change theory include self-monitoring of thoughts and 
behaviors, problem solving, realistic goal setting, cognitive restructuring, stimulus 
control, and relapse prevention (12). This intervention utilized self-monitoring of diet and 
exercise habits, goal-setting, and problem-solving. Stimulus control was also utilized as 
needed by individual participants. This theoretical framework has been shown to be 
successful in improving lifestyle behaviors to facilitate weight loss (13).  
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Participants were provided with an individualized energy prescription, calculated 
with the National Academy of Sciences/Institute of Medicine (NAS/IOM) total energy 
expenditure prediction equation: (TEE = 387 – (7.31 x age) + physical activity 
(PA)[(10.9 x weight(kg)) + (660.7 x height)] ± 160), using a PA of 1.14, which 
corresponds to a low activity level (14). An additional 330 kcal were added for fully 
breastfeeding women and 150 kcal for women who were combining breastfeeding and 
formula feeding. A reduction of 500 kcal/day was added to achieve a goal weight loss of 
0.5 kg/week.  
At the start of the intervention, the RD made a home visit to participants in the 
intervention group to review study procedures. Participants were provided with their 
recommended energy intake based on the NAS/IOM TEE equation. This value ranged 
from 1800 to 2200 kcal per day. Participants were given a sample meal plan for this 
energy level with recommended number of servings from each food group based on the 
USDA MyPlate recommendations for lactating women. Several participants restricted 
dietary intake of certain foods or food groups (dairy, animal proteins, grains) due to 
maternal or infant intolerances and allergies, vegetarianism, or personal preferences. In 
these instances, the RD instructed the participant on alternative ways to meet nutritional 
needs (calcium, protein, fiber).  
Participants were instructed to record dietary intake at least three days weekly for 
the duration of the study using the online USDA SuperTracker program (15). Participants 
were instructed on how to track their diet using this tool at the initial home visit. 
Instruction included how to enter daily food intake, including portion size, creating 
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recipes, adding frequently consumed foods, and creating food combinations. 
SuperTracker provides a chart diagraming intake of each food group, oils, saturated fat, 
sodium, and empty kilocalories. Participants were instructed to aim to meet 
recommendations for each food groups, and stay below maximum levels for oils, 
saturated fat, sodium, and empty kilocalories. An educational handout was provided to 
participants with screenshots of the website and step-by-step instructions.  
At this home visit, participants were provided with a pedometer (Omron 
Healthcare, Inc., Lake Forest, IL) and instructed to work up to a goal of 10,000 steps 
daily. Women were instructed to increase steps from baseline amounts by 1,000 steps 
every week until the goal was met. Participants were also provided with an alternative 
goal of walking at least 3,000 aerobic steps daily. Aerobic steps are classified as walking 
at least 100 steps per minute for at least 10 minutes. Walking 3,000 aerobic steps has 
been shown to be the equivalent of 30 minutes of brisk walking (16). Participants were 
instructed to wear the pedometer on a daily basis and were instructed to record daily 
steps, aerobic steps, and other aerobic activity. Pedometer logs were reported by 
participants to the RD every two weeks. Participants were provided with an educational 
handout at the initial visit, which provided step goals, as well as suggestions on how to 
increase daily steps.  
Dietary intake records were reviewed by the RD every two weeks, and 
individualized dietary recommendations were provided to participants by telephone or 
email. Recommendations focused on strategies to reduce energy intake, balance intake of 
all food groups, and reduce portion size. Barriers to compliance were also addressed at 
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this time. Participants also received educational handouts every two weeks, focusing on 
portion control, intuitive eating, meal planning, grocery shopping, and dining out. 
Pedometer logs were reviewed by the RD every two weeks. Recommendations were 
made to participants on ways to increase daily steps.  
Control group. Participants in the control group were instructed to not change 
their dietary habits or engage in a structured exercise program for 12 weeks. After 
completion of the endpoint measurements, control group participants received all 
intervention materials, including the pedometer, educational materials, and individualized 
dietary prescription. Participants in both groups were contacted biweekly by telephone or 
email and asked about breastfeeding status, birth control use, nutritional supplement use, 
return of menses, and physical activity.  
Laboratory Measurements 
 Laboratory measurements were obtained for all eligible participants at baseline 
and after the 12-week intervention. These measurements included anthropometrics, body 
composition, and cardiovascular fitness.  Participants were randomized after both dietary 
recalls were obtained.  
Anthropometrics. Height was measured using a digital stadiometer (235 
Heightronic Digital Stadiometer, Snoqualmie, WA). Weight was measured without shoes 
and in light clothing using a calibrated digital scale (Tanita BWB-800S, Arlington 
Heights, IL). A Gulick tape was used to measure waist and hip circumference to the 
nearest 0.1 cm. Waist circumference was measured at the narrowest point of the torso, 
above the umbilicus and below the xiphoid process (17). Hip circumference was 
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measured at the maximum circumference of the hip (17). Sagittal diameter was measured 
using abdominal calipers (Lafayette Instrument Company, Lafayette, IN) at the largest 
diameter between the umbilicus and xiphoid process (17).  
Body Composition. Percent body fat, fat-free mass, and trunk fat were measured 
by dual-energy x-ray absorptiometry (DXA: Lunar Prodigy Advance, GE Healthcare, 
Madison, WI). Trunk fat included the neck, chest, abdominal, and pelvic areas. A trained 
DXA technician conducted all measurements. Participants were placed in a supine 
position on the x-ray table while the fan-beam scanner made a series of transverse scans 
from head to toe in 0.6 to 1.0 cm intervals. Body composition was analyzed using 
enCORE 2011 software version 13.60. 
Cardiovascular Fitness. Cardiovascular fitness was determined through a 
modified Balke protocol using a submaximal treadmill test (17). Participants wore a heart 
rate (HR) monitor (Polar, Inc., Woodbury, NY) to determine resting heart rate (RHR) and 
HR throughout the exercise testing. Participants warmed up on the treadmill for three 
minutes, then selected a brisk, but slightly uncomfortable speed at either a walk (< 3.7 
mph) or a jog (> 3.7 mph). The treadmill speed remained constant throughout the test. 
Starting with an incline of 0%, the incline of the treadmill was increased by 2.5% every 
three minutes. Heart rate and perceived exertion were recorded every minute during the 
test. Perceived exertion is a subjective rating of effort from 6 to 20. A rating of 6 
corresponds with an extremely easy effort, while a rating of 20 corresponds with an 
extremely hard effort. The test was terminated once the participant’s heart rate reached 
85% of their predicted heart rate maximum (calculated using the heart rate reserve (HRR) 
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formula: HRR = [(220-age-RHR) x 85% + RHR]) or if the participant asked to stop. 
Predicted VO2 max was calculated using one of the following equations based on 
whether the participant walked or jogged for the test (17):  
VO2 (walking) = 0.1[speed (m·min
-1)] + 1.8[speed (m·min-1) x grade] + 3.5 mL·kg-1·min- 
VO2 (jogging) = 0.2[speed (m·min
-1)] + 0.9[speed (m·min-1) x grade] + 3.5 mL·kg-1·min- 
Predicted VO2 max was calculated using a linear regression model with HR as the 
independent variable and predicted VO2 max as the dependent variable. Fitness percentile 
values for VO2 max by age for women were determined using American College of 
Sports Medicine guidelines (17).  
Dietary Intake 
 Dietary intake was assessed in the week following laboratory assessments by two 
24-hour dietary recall sessions collected by telephone or in person using the Minnesota 
Nutrition Data System for Research (NDSR, Nutrition Coordinating Center, University of 
Minnesota, MN) software, on two separate days of the same week. Attempts were made 
to include one weekend day. However, this was not always feasible due to participants’ 
schedules. This program utilizes a multipass procedure to obtain an accurate record of 
dietary intake. This method has been previously validated against doubly labeled water as 
an accurate measure of energy intake (18, 19). Data from the two days of diet recall were 
averaged and used to determine the Healthy Eating Index (HEI) score. The HEI measures 
compliance with dietary recommendations based on the 2010 Dietary Guidelines for 
Americans. It consists of 12 components: total fruit, whole fruit, total vegetables, greens 
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and beans, whole grains, dairy, total protein foods, seafood and plant proteins, fatty acids, 
refined grains, sodium, and empty calories (20). Maximum scores for components are 5, 
10, and 20, depending on the component, with a maximum score of 100.  
Lactation Status  
Participants in both groups were asked biweekly how they were feeding their 
infant. A lactation score was calculated for all participants as follows: for every week 
since delivery, a score of 2 was assigned for fully breastfeeding (less than 4 ounces of 
formula daily), a score of 1 for mixed feeding (breastfeeding and formula feeding), and a 
score of 0 for fully formula feeding, for a maximum score of 36 to 52 depending on when 
the participant entered the study. The total lactation score at each time point was divided 
by the maximum possible score to determine a lactation score percentage. Women were 
considered: 1) predominantly formula feeding if they had a score less than 25% of the 
maximum, 2) low intensity, low duration breastfeeding with a score between 25-75% of 
the maximum or 3) high intensity, high duration breastfeeding with a score greater than 
75% of the maximum.  
Perceived Stress Scale 
 Perceived stress levels of participants were measured using the Perceived Stress 
Scale at baseline (21). This scale measures the degree to which an individual perceives 
life situations as stressful, unpredictable, or uncontrollable, using 10 questions about 
feelings and thoughts over the last month. Participants rate how often they feel a certain 
way in response to the questions on a 5-point Likert scale from 0 (never) to 4 (very 
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often). Total scores are the sum of all questions, with a maximum score of 40. Higher 
scores indicate higher levels of perceived stress.  
Statistical Analysis 
 Data was analyzed using JMP software (v.11.0.0, SAS Institute, Cary, NC). 
Student’s t-test (continuous variables) and χ2 analysis (categorical variables) were used to 
compare differences in baseline characteristics between the intervention and control 
groups. Repeated measures ANOVA was used to test for time by group interaction for 
weight, body composition, waist and hip circumference, sagittal diameter, cardiovascular 
fitness, and dietary intake. Data are reported as mean ± SEM, with significance set at p ≤ 
0.05.  
Results 
Seventy-eight women were screened for eligibility; 43 were ineligible to 
participate (Figure 3.1).  Baseline measurements were conducted on 35 participants. 
However, only 34 participants were randomized after baseline measurements (11.1 ± 2.8 
weeks postpartum) into the intervention group (n = 17) or control group (n = 17). Three 
participants did not complete the endpoint measurement (two in the control group, one in 
the intervention group). Baseline characteristics of the women who discontinued the 
study did not differ from the women who completed the study. However, women who 
dropped out of the study were more likely to be low intensity, low duration breastfeeding 
compared to women who completed the study (χ2 = 4.7, P = 0.03).  
There were no significant differences between groups at baseline (Table 3.1). 
Three women in the intervention group and four women in the control group had 
 
 
52 
measured BMI ≥ 30 kg/m2.  One woman in the intervention group and four women in the 
control group had measured BMI < 25 kg/m2, but were at least 4.5 kg heavier than they 
were pre-pregnancy. Baseline BMI ranged from 23.5-33.1 kg/m2 in the intervention 
group and 23.4-34.1 kg/m2 in the control group. In the intervention group, 100% of the 
participants were high intensity, high duration breastfeeding (lactation score percentage 
range 79-100%), compared to 80% in the control group (lactation score percentage range 
50-100%).  
  
Figure 3.1. Study Enrollment Flow Chart. 
78 women screened for 
eligibility 43 Ineligible 
BMI (n = 15), unable to 
contact (n = 9), declined 
participation after baby 
born (n = 19) Baseline Measurements 
(n = 35) 
Not Randomized (n = 1) 
Lost to follow up 
Intervention Group 
 n = 17) 
Control Group (n = 17) 
Dropped (n = 1) 
Lost to follow up  
Endpoint Measurement 
(n = 16) 
 
Endpoint Measurement 
(n = 15) 
 
Dropped (n = 2) 
Lost to follow 
up, pregnant  
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Table 3.1. Baseline Characteristics of the Intervention and Control Groups. 
 Intervention  
(n = 16) 
Control  
(n = 15) 
Age (yr) 31.4 (1.0) 31.1 (1.0) 
Pre-pregnancy BMI (kg/m2) 26.2 (0.9) 24.8 (1.0) 
Time since delivery (wk) 11.6 (0.7) 10.5 (0.7) 
Pregnancy weight gain (kg) 17.6 (1.6) 18.6 (1.7) 
Postpartum weight retention (kg)a 6.1 (1.9) 6.5 (2.0) 
Weight loss delivery to start of study (kg) 4.9 (0.8) 5.2 (0.9) 
Parity   
    Primiparous 12 8 
    Multiparous 4 7 
Education   
    Some college 2 2 
    College degree 7 9 
    Graduate degree 7 4 
Marital status   
    Married 16 13 
    Single 0 2 
Breastfeeding   
    High intensity, high duration BF 16 12 
    Low intensity, low duration BF 0 3 
    Formula feeding 0 0 
Race   
    White 15 14 
    Black 1 1 
Employment status   
    Working at least part-time 12 10 
    Not working 4 5 
Income   
    < $20,000 0 1 
    $20,000-29,999 0 1 
    $30,000-39,999 3 0 
    $40,000-49,999 1 2 
    $50,000-59,999 0 2 
    > $60,000 12 9 
Data are mean (SEM) 
BF, breastfeeding 
a Postpartum weight retention is defined as weight at baseline above pre-pregnancy 
weight. 
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Table 3.2 Body Composition and Cardiovascular Fitness in the Intervention and 
Control Groups. 
 Baseline Endpoint Change  Time  Interaction  
Weight (kg)*       
    Intervention 76.7 (2.2) 72.9 (2.4) -3.8 (0.7)  <0.001 0.043 
    Control 74.2 (2.3) 72.3 (2.7) -1.8 (0.7)    
BMI (kg/m2)*       
    Intervention 28.4 (0.7) 27.0 (0.8) -1.4 (0.2)  <0.001 0.034 
    Control 27.1 (0.8) 26.5 (0.9) -0.7 (0.3)    
WC (cm)**       
    Intervention 86.5 (1.8) 82.1 (1.9) -4.4 (0.6)  <0.001 0.004 
    Control 86.6 (1.9) 84.9 (2.0) -1.7 (0.6)    
HC (cm)       
    Intervention 107.0 (2.1) 102.1 (2.1) -4.1 (0.7)  <0.001 0.107 
    Control 104.8 (2.2) 102.2 (2.6) -1.9 (0.7)    
SD (cm)*       
    Intervention 24.3 (0.6) 22.5 (0.7) -1.8 (0.3)  <0.001 0.049 
    Control 24.8 (0.7) 23.8 (0.7) -1.0 (0.3)    
Fat mass (kg)       
    Intervention 32.2 (1.7) 28.6 (1.7) -3.5 (0.6)  <0.001 0.053 
    Control 30.3 (1.8) 28.6 (2.1) -1.8 (0.6)    
Fat free mass (kg)       
    Intervention 44.5 (1.0) 44.2 (1.0) -0.3 (0.2)  0.312 0.473 
    Control 43.8 (1.0) 43.8 (1.1) 0.0 (0.3)    
% Body fat (%)       
    Intervention 41.7 (1.2) 38.9 (1.3) -2.8 (0.5)  <0.001 0.085 
    Control 40.5 (1.3) 39.0 (1.5) -1.4 (0.6)    
Trunk fat (kg)*       
    Intervention 16.0 (1.0) 14.2 (1.1) -1.8 (0.4)  <0.001 0.039 
    Control 15.6 (1.0) 14.9 (1.2) -0.7 (0.4)    
VO2 max (mL/kg/min)*       
    Intervention 30.6 (1.3) 33.2 (1.4) 2.6 (1.0)  0.156 0.043 
    Control 31.1 (1.4) 30.6 (1.1) -0.5 (1.1)    
VO2 max (L/min)       
    Intervention 2.3 (0.1) 2.4 (0.1) 0.1 (0.1)  0.761 0.109 
    Control 2.3 (0.1) 2.2 (0.1) -0.1 (0.1)    
WC: waist circumference; HC: hip circumference; SD: sagittal diameter 
Data are mean (SEM) 
Significant time by group interaction, *p < 0.05, **p <0.01, RMANOVA  
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The intervention group lost significantly more weight than the control group 
(Table 3.2). Weight change in the intervention group ranged from -8.6 to 1.2 kg, while 
weight change in the control group ranged from -5.4 to 2.2 kg over 12 weeks. Seven 
women (44%) of the women in the intervention group and 2 women (13%) in the control 
group lost greater than 5.0 kg. Eight women (50%) in the intervention group and two 
women (13%) in the control group returned to their pre-pregnancy weight by endpoint. 
The intervention group had significantly greater reductions in BMI, trunk fat mass, waist 
circumference, hip circumference, and sagittal diameter than the control group. 
The intervention group reduced their energy intake by -29 ± 143 kcal per day, 
while the control group reduced energy intake by -81 ± 148 kcal per day. This difference 
was not significant over time or by group. However, the average energy deficit at 
baseline for the intervention group was -529 ± 111 kcal. There was no significant time by 
group interaction for macronutrient content (Table 3). However, the percent of energy 
from protein increased significantly over time for both groups (P = 0.03). Both groups 
had reductions in HEI scores, but the differences were not significant between groups or 
over time. The number of women meeting the recommendation for good diet quality 
(score over 80) in the intervention group increased from 3 to 5 (17% to 27%), while the 
number of women meeting the recommendations in the control group decreased from 4 to 
3 (31% to 20%). 
Predicted VO2 max improved by 9.3 ± 3.5% for the intervention group, while 
decreasing by 0.5 ± 3.1% in the control group (P = 0.03). This represents a significant 
increase in VO2 max percentile by age in the intervention group of 12.5 ± 4.4% compared 
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to a reduction of 1.3 ± 4.5% in the control group (P = 0.03). Change in predicted VO2 
max was not associated with change in weight. In order to eliminate the effect of weight 
loss on VO2 max, baseline predicted VO2 max was divided by endpoint weight to 
determine predicted endpoint VO2 max. This was compared to the observed VO2 max at 
endpoint. The intervention group had observed values 0.2 L/min higher than compared to 
values 0.2 L/min lower than expected in the control group (P = 0.02). Average 12 week 
pedometer steps for the intervention group was 6937 ± 647 steps per day. There was a 
significant increase in pedometer steps over the 12 week intervention (Figure 3.2) from 
6,942 ± 691 steps at 2 to 7,316 ± 786 steps at week 12 (P = 0.04). 
Table 3.3. Dietary Intake of Intervention and Control Groups at Baseline and 
Endpoint. 
 Intervention (n = 16)  Control (n = 15) 
 Baseline Endpoint  Baseline Endpoint 
Energy      
      Kcal 2052 (117) 2023 (87)  2130 (120) 2049 (123) 
      kcal/kg 26.8 (1.6) 27.9 (2.3)  29.2 (1.7) 28.6 (1.7) 
CHO      
      grams 254.7 (17.0) 238.4 (23.9)  277.0 (17.6) 250.4 (16.1) 
      % of kcal 49.9 (1.7) 47.4 (2.0)  51.9 (1.8) 49.0 (2.0) 
Fat      
      grams 82.4 (7.6) 78.0 (8.3)  81.9 (7.9) 81.5 (7.5) 
      % of kcal 35.4 (1.7) 34.3 (1.7)  34.3 (1.7) 35.4 (1.8) 
Protein      
      grams 78.3 (5.6) 88.1 (9.6)  84.7 (5.7) 87.5 (4.6) 
      % of kcal* 15.5 (0.9 17.5 (1.0)  16.1 (0.9) 17.4 (0.8) 
      g/kg 1.03 (0.08) 1.21 (0.12)  1.17 (0.09) 1.22 (0.06) 
HEI Score 67.7 (3.4) 66.9 (3.5)  66.0 (3.6) 62.3 (4.4) 
Data are mean (SEM) 
Significantly different over time, *p < 0.05, RMANOVA 
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Participants were asked to wear the pedometer and record steps daily for 12 
weeks with a total of 84 days to meet 100% compliance. The intervention group recorded 
pedometer steps an average of 75 ± 2 days out of a possible 84 days (89% compliance, 
range 77-100%). Two participants met the recommended 10,000 steps daily, while an 
additional three participants walked over 9,000 steps daily. Participants who walked the 
most steps lost significantly more weight than those who walked less (r = -0.57, P = 
0.03).  
By the end of the intervention, three women in the intervention group and three 
women in the control group had moved to the low intensity, low duration breastfeeding 
category. One woman in the control group began fully formula feeding her infant. 
 
Figure 3.2. Pedometer Steps of the Intervention Group over the 12 Week 
Intervention.  
Bolded line: average steps of all participants.  
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Discussion 
 Women in the intervention had significantly greater reductions in weight and BMI 
compared to women in the control group. However, their average weight loss (3.8 ± 0.7 
kg was less than the range of 4.8 to 8.3 kg reported in some other studies in postpartum 
women (5-10). Women lost an average of 0.3 kg/week, which was lower than the target 
weight loss of 0.5 kg/week. Other studies reported an average weekly weight loss ranging 
from 0.3 to 0.7 kg/week. Three of these studies recruited exclusively breastfeeding 
women (7, 8, 10). Since lactation increases energy expenditure (22), this may have 
contributed to increased postpartum weight loss. Additionally, the exercise sessions were 
supervised in the home in two studies (7, 8), which may have facilitated compliance with 
the exercise prescription, leading to increases in weight loss. 
 Our results are consistent with a study by Leermaker et al of 92 postpartum 
women (5). Their study utilized a correspondence-based intervention over 6 months, and 
included self-monitoring of dietary intake, and moderate aerobic activity. Weight loss in 
the intervention group was 0.3 kg/week and 0.2 kg/week in the control group. 
Additionally, most women in this study returned to work during the intervention, limiting 
compliance with the intervention, particularly the exercise component. Other studies 
recruited women who were not working at the time of the intervention (7, 10).  
While we did not observe significant differences in total and percent fat mass loss 
between groups, the intervention group had significantly greater reductions in abdominal 
obesity, as measured by waist circumference, sagittal diameter, and trunk fat. Waist 
circumference has been found to be a better predictor of cardiovascular disease risk and 
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metabolic syndrome compared to BMI (23). Whereas increased visceral adiposity 
increases the risk of cardiovascular diseases, reductions in abdominal obesity decrease 
the risk of chronic disease (24).  
 Despite no differences in energy intake between groups over time, a weight loss 
of 0.3 kg/week was observed. This is in contrast with other interventions, which observed 
reductions of energy intake ranging from 382 to721 kcal (5-8, 10). One reason for this is 
that compliance with the intervention (monitoring dietary intake and step count) 
decreased after 6 to 8 weeks for many participants. This corresponded with participants 
returning to work. However, the average calorie prescription for 0.5 kg/week weight loss 
was 2081 kcal for intervention participants. So, despite the lack of change in energy 
intake, participants were already reporting energy intakes at baseline that were 529 kcal 
lower than energy needed to maintain their weight.  Additionally, the average weight loss 
from baseline to the 6 week midpoint measurement was -2.5 kg in the intervention group, 
while weight loss from 6 weeks to endpoint was -1.7 kg. Weight loss slowed during the 
second half of the intervention, with several participants re-gaining some weight. Rapid 
initial weight loss in the first few days or weeks of energy restriction is related to a 
reduced energy content of weight change (4,858 kcal/kg), comprised mainly of glycogen, 
protein, and water (25).  However, metabolic adaptations occur over the next few months, 
resulting in reduced energy expenditure and increased fat oxidation requiring greater 
energy deficits, which explains the slower weight loss observed over time (25). 
Therefore, the generally practiced rule that a reduction in energy intake of 500 kcal per 
day will result in a steady-state weight reduction of 0.5 kg per day is inaccurate, 
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overestimating expected weight loss over time. The National Institute of Health Body 
Weight Planner is a new online tool, which more accurately predicts weight change over 
time (26). This may be a useful tool for setting realistic, personalized goals for future 
interventions.   
Another explanation for the greater weight loss observed in the intervention group 
may have been related to increased energy expenditure from physical activity.  
Participants in this study were unable to achieve the aerobic exercise goal of 10,000 steps 
per day. However, the intervention group increased steps over the 12 week intervention, 
averaging 6,937 steps per day. This is above the average among American women of 
5,210 steps daily (16). Additionally, 13% of women in the intervention group averaged 
over 10,000 steps. Aerobic exercise in this intervention was not supervised, with 
participants working toward the step goal on their own. This may have contributed to the 
inability to meet the goal. A previous study reported that when given a pedometer with an 
aerobic exercise goal of 10,000 steps daily, postpartum women were only able to achieve 
4,838 steps daily (8). However,  meta-analysis of physical activity interventions found 
that participants given a pedometer increased their activity by 2,004 steps per day more 
than control participants, and having a step goal and recording steps in a diary were 
predictors of increased activity (27). This suggests that using a pedometer is a valid 
strategy for increasing physical activity. Additionally, in this study, participants who 
walked more steps lost the greatest amount of weight. This may be related to increased 
physical activity in the intervention group as observed by a significant increase in VO2 
max of 2.6 mL/kg/min in the intervention group and a decrease of 0.5 mL/kg/min in the 
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control group. This represents a 12.5% increase in percentile for age in the intervention 
group and a 1.3% decrease in percentile for age in the control group. These results 
suggest that physical activity, in addition to energy restriction, may be beneficial to 
weight loss in postpartum women.  
Diet quality, as measured by the Healthy Eating Index, did not change in either 
group as a result of the intervention. The mean diet quality score at baseline for the entire 
sample was 66.3, which is below the recommended HEI score for good diet quality of 
more than 80 (20). However, this is above the national average of 53.5 according to the 
2007-2008 National Health and Nutrition Examination Survey (28). One study in low 
income, early postpartum women found a lower HEI score of 42.8 (29). However, our 
results are consistent with the KAN-DO study, which found an average baseline HEI 
score for overweight and obese postpartum women of 64.4 (30). Diet quality in their 
study did not change after a family-based diet and exercise intervention, and they found 
that baseline energy intake was a stronger predictor of weight change in the postpartum 
period. During a weight loss intervention in postpartum women, it may be challenging to 
meet recommendations for all food groups related to decreased energy intake, as well as 
lack of time to prepare healthy foods. In addition, breastfeeding women may intentionally 
restrict consumption of certain food groups, such as milk, beans, dairy, and grains due to 
infant intolerance (31). While improving diet quality should be an important priority in 
the postpartum period, focusing on reduction of energy intake has a greater impact on 
weight change.  
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 This study used individualized dietary prescriptions, biweekly telephone or email 
counseling, self-monitoring of dietary intake using the USDA SuperTracker program, and 
self-monitoring of physical activity using pedometers.  Our results were similar to a 
recent study of low-income, postpartum women that used a technology-based 
intervention, which included self-monitoring of weight and physical activity, biweekly 
telephone calls, daily text messages, and a social media support group. They reported that 
women in the intervention group lost 3.6 kg more than a usual care group (32).  
Another study in overweight and obese fully breastfeeding women utilized the 
online USDA MyPyramid tool, a precursor to SuperTracker, and reported that the 
intervention group significantly reduced energy intake compared to the control group 
(31). Participants in this study used MyPyramid an average of 9.6 weeks of the 16 week 
intervention. However, similar to the present study, there was no association with weeks 
used and weight loss. This study also incorporated weekly face-to-face dietary counseling 
with a RD. These studies suggest that online diet tracking tools may be beneficial to 
reducing energy intake when combined with individualized dietary counseling via 
telephone, text messaging, or email. These types of interventions are time and labor-
saving, and may be a more practical method for delivering individualized 
recommendations in order to promote weight loss in postpartum women. 
Overall, compliance with the study intervention was good, with a high percentage 
of participants completing dietary and physical activity records. Participant retention was 
high, with a 9% attrition rate, suggesting that this type of intervention is feasible for this 
population. Other studies experienced attrition rates of 31% (5) and 42% (6). This may 
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reflect a longer study duration or the use of group classes, which are time intensive. 
Ostbye et al found that participants attended an average of 3.8 out of 8 classes and 3.3 out 
of 6 counseling calls (9). They did not observe significant weight loss between groups. 
This suggests that a class format may not be a feasible strategy for postpartum women. 
Studies that utilize home-based activities and self-monitoring have lower dropout rates 
and greater weight loss among intervention participants (7, 8, 10), indicating that this 
type of intervention may be more appropriate for postpartum women due to the increased 
time constraints of caring for an infant. Furthermore, self-monitoring of diet and physical 
activity has been shown to have a positive impact on weight loss (33).   
In this study, increased perceived stress was associated with smaller reductions in 
weight. PSS scores in this study population (12.9) were lower than in other postpartum 
populations, which ranged from 15.8 to 18.3 (34-36). However, this is similar to average 
PSS scores among women of 13.7 (37). While there are no studies examining the 
relationship between perceived stress and weight change in postpartum women, increased 
stress levels have been associated with increased BMI (38), higher fat intake (39), and 
lower physical activity (38,40). Additionally, scores on the PSS have been found to be 
associated with increased risk of the metabolic syndrome (41) and cardiovascular disease 
(42).  
Limitations to this study are the small sample size and lack of long-term follow 
up.  Also, the study participants were mostly white and college educated, limiting the 
generalizability of the results to women of other race or ethnic groups and lower 
education levels. Finally, we did not have information on physical activity in the control 
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group. Determining the number of steps at baseline and endpoint in the control group, 
would allow for comparisons with the intervention group. Strengths of this study include 
the randomized, controlled design of the study, low dropout rate of participants, and high 
compliance with self-monitoring.  
In conclusion, a RD-guided diet and exercise intervention was successful in 
promoting modest weight loss and loss of abdominal fat in postpartum women. In 
addition, this intervention increased physical activity and improved cardiovascular fitness 
levels, which may be responsible for the increased weight loss observed in the 
intervention group. While weight loss in this study was lower than in previous studies, 
the strategies used in this intervention were time and labor-saving. These strategies may 
be a practical method for reducing postpartum weight retention, lowering the risk of 
obesity among women of childbearing age.
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CHAPTER IV 
 
EFFECTS OF A WEIGHT LOSS PROGRAM ON METABOLIC SYNDROME 
RISK FACTORS AND INFLAMMATION IN POSTPARTUM WOMEN 
     Formatted for publication in the American Journal of Clinical Nutrition 
Introduction 
Metabolic syndrome (MetSyn) is a cluster of symptoms that have been shown to 
increase the risk of cardiovascular disease and type 2 diabetes (1). The National 
Cholesterol Education Program III (NCEP III) defines MetSyn in women as waist 
circumference greater than 88 cm, triglycerides greater than 150 mg/dL, HDL cholesterol 
less than 50 mg/dL, blood pressure greater than 130/85 mm Hg, and fasting glucose 
greater than 100 mg/dL (2). A diagnosis is made if 3 or more of the above criteria are 
met. In the United States, 23.4% of women meet the criteria for MetSyn (1). Obesity, 
specifically abdominal obesity, increases the risk of developing MetSyn (3).  
Obesity is also associated with low grade, systemic inflammation (4). Adipose 
tissue has been found to secrete pro-inflammatory cytokines, including IL-6 and TNF-α 
(5). These cytokines stimulate production of a circulating inflammatory protein, C-
reactive protein (CRP) (6), which is associated with MetSyn. A study by Ridker et al 
found that CRP levels increased as the number of MetSyn characteristics increased, with 
CRP of 3.01 mg/L associated with a diagnosis of MetSyn (7). .
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Pregnancy is associated with physiologic changes, including insulin resistance 
(8), elevated cholesterol and triglycerides (9, 10), and increased inflammation (11-15) 
While these changes typically return to pre-pregnancy levels after delivery, excessive 
weight retention associated with pregnancy may delay this response, increasing the risk 
of MetSyn and chronic disease later in life (16). Increasing parity has also been 
associated with increased risk of obesity, elevated lipid profile, and diabetes (17). A study 
by Gunderson et al found that parity is associated with an increased risk of developing 
MetSyn (18).  
 Lactation may protect women against development of MetSyn by lowering risk 
factors during the postpartum period. Triglyceride levels return to baseline 13 weeks 
earlier in breastfeeding women compared to formula feeding women (10), while HDL 
levels are higher in lactating women (19). Lactation has also been shown to reduce 
insulin resistance and improve glucose homeostasis in women with and without a history 
of gestational diabetes (8, 19).  
In addition to reducing risk factors during the postpartum period, breastfeeding 
may also reduce the risk of developing MetSyn later in life. A cross-sectional study by 
Ram et al found that the duration of lactation was inversely correlated with systolic and 
diastolic blood pressure, fasting glucose, triglycerides, total cholesterol, and LDL 
cholesterol, and positively correlated with HDL cholesterol, while the duration of 
breastfeeding was associated with a reduced risk of developing MetSyn in midlife (20).  
Few studies have examined the impact of weight loss on MetSyn risk factors and 
inflammation in postpartum women. Studies that examined the effect of exercise on risk 
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factors found that moderate exercise alone did not improve blood lipids (21, 22), but 
there was a significant correlation between change in VO2 max and change in insulin 
response (21). Women in both these studies had a normal BMI, and changes in body 
weight did not differ between the intervention and control groups. Studies that combine 
an energy restriction with moderate exercise have found greater reductions in waist 
circumference (23, 24), LDL cholesterol (23, 24), total cholesterol (24), insulin (24) and 
glucose (23), and increased HDL cholesterol (24) and adiponectin (23). However, they 
did not observe changes in inflammatory proteins. Stendell-Hollis et al found that TNF-α 
levels were reduced with a Mediterranean-style and MyPyramid diet, but no significant 
differences were observed between groups (25). These studies show that weight loss 
associated with dietary or dietary plus exercise interventions may improve 
cardiometabolic risk factor and inflammation. However, no studies to our knowledge 
have compared the impact of body composition changes on the occurrence of MetSyn in 
postpartum women.  
In a randomized, controlled trial, we found that a 12-week, home-based diet and 
exercise intervention reduced weight by 5% in postpartum women, with reductions in 
waist circumference, sagittal diameter, and abdominal fat mass, and improvements in 
cardiovascular fitness. In this paper, we examine the effects this intervention on MetSyn, 
cardiometabolic risk factors, and inflammation among postpartum women.  
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Methods 
Study Participants 
Participants were part a home-based, self-monitoring weight loss intervention. 
Women were recruited from the Greensboro, NC community. Research staff distributed 
recruitment flyers at pre- and postnatal classes at the local Women’s Hospital. Flyers 
were also posted in obstetric and pediatric medical offices. Women with a BMI between 
25 to 35 kg/m2 or who were at least 4.5 kg heavier than their pre-pregnancy weight were 
eligible to participate when they were between 6 and 14 weeks postpartum. Other 
eligibility criteria include sedentary lifestyle, age 18 years and older, non-smoker, 
singleton birth, and free of chronic disease. Women were screened by telephone or email 
after the delivery of their baby. Eligibility was determined by self-reported weight. 
Participants were required to receive medical clearance from their physician before 
starting the intervention.  
Study Design 
This was a 12-week randomized, controlled clinical trial (ClinicalTrials.gov 
NCT01668316), approved by the University of North Carolina at Greensboro 
Institutional Review Board. Participants were randomized using block randomization, 
and stratified by baseline BMI and weeks postpartum.   
A more detailed description of the intervention is presented in Chapter III. 
Briefly, the intervention involved self-monitoring of diet and exercise behaviors, led by a 
registered dietitian. Participants were instructed on reducing energy intake by500 
kcal/day to achieve a weight loss of 0.5 kg/week. Energy prescriptions were calculated 
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using the National Academy of Sciences/Institute of Medicine equation with adjustments 
made based on lactation status (26). Participants were asked to track their dietary intake 
using the online USDA SuperTracker program on at least 3 days a week (27). They were 
also given a pedometer (Omron Healthcare, Inc., Lake Forest, IL) with a daily exercise 
goal of 10,000 steps. Diet and pedometer records were reviewed biweekly by the 
registered dietitian, and individualized recommendations were provided to participants. 
The control group was instructed to continue their current diet and exercise habits.  
Measurements 
 Anthropometrics, body composition, and metabolic and inflammatory biomarkers 
were measured at baseline and after the 12-week intervention.  
Anthropometrics. Height and weight were measured using a digital stadiometer 
(235 Heightronic Digital Stadiometer, Snoqualmie, WA) and a calibrated digital scale 
(Tanita BWB-800S). A Gulick tape was used to measure waist circumference at the 
narrowest point of the torso, and hip circumference was measured at the maximum 
circumference of the hip (28).  
Body Composition. Fat mass, fat mass, and trunk fat mass were measured by 
dual-energy x-ray absorptiometry (DXA: Lunar Prodigy Advance, GE Healthcare, 
Madison, WI, Encore 2011 software version 13.60) by a trained DXA technician. Trunk 
fat was measured as the fat mass in the neck, chest, abdominal, and pelvic regions.  
Blood Biomarkers. Fasting blood samples were drawn by a trained phlebotomist. 
Since anti-inflammatory medications or acute illness may alter concentrations of 
inflammatory proteins, participants were instructed to not take these medications within 
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24 hours of the initial laboratory visit. Laboratory measurements were rescheduled if the 
participant was ill within two weeks of the initial visit. Blood samples were left at room 
temperature for 20 minutes to allow for clotting, then spun in a centrifuge at 3000 rpm at 
4°C for 30 minutes. Serum was partitioned into micro-centrifuge tubes and stored at -
80°C. ELISA kits were used to determine concentrations of high sensitivity -CRP (hs-
CRP; Genway Biotech, Inc., San Diego, CA) and insulin (Mercodia, Uppsala, Sweden). 
Colorimetric assay was used to measure glucose concentrations (Cayman Chemical, Ann 
Arbor, MI), total, HDL, and LDL cholesterol, and triglycerides (Wako Chemical, 
Richmond, VA). Insulin resistance was calculated using the homeostatic model 
assessment of insulin resistance (HOMA-IR) using the equation: HOMA-IR = [Fasting 
glucose (mg/dL) x Insulin (μU/mL)]/405 (29).  
Blood Pressure. Blood pressure was measured after resting for 5 minutes in a 
seated position using a digital monitor (LifeSource UA-853, San Jose, CA). Two blood 
pressure readings were obtained, and the results were averaged.  
Cardiovascular Fitness. A submaximal treadmill testing was used to determine 
predicted maximal oxygen consumption (VO2 max) using a modified Balke protocol 
(28). Resting heart rate (RHR) was determined using a heart rate (HR) monitor (Polar, 
Inc., Woodbury, NY) prior to exercise testing. This was used to determine the maximum 
HR reserve (HRR) using the formula, HRR = (220-age-RHR) x 0.85 + RHR. After a 
three minute warm up, participants selected a brisk, slightly uncomfortable speed at either 
a walking (< 3.7 mph) or jogging (> 3.7 mph) pace. Every three minutes the incline of the 
treadmill was increased by 2.5%. HR and perceived exertion were recorded every minute. 
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The test was concluded when the participant’s heart rate reached 85% of their predicted 
maximum HR or if she asked to stop. Predicted VO2 max was determined using a linear 
regression model (28).  
Metabolic Syndrome 
Metabolic syndrome was determined based on the NCEP III criteria. A participant 
was considered to have MetSyn if they met at least three of the following criteria: waist 
circumference greater than 88 cm, triglycerides greater than 150 mg/dL, HDL cholesterol 
less than 50 mg/dL, blood pressure greater than 130/85 mm Hg, and fasting glucose 
greater than 100 mg/dL (2).  
C-Reactive Protein Risk 
 CRP risk categories were assigned based on the American Heart Association and 
Centers for Disease Control and Prevention recommendations based on risk of coronary 
outcomes as follows: less than 1 mg/L (low risk), 1.0-3.0 mg/L (medium risk), and 
greater than 3.0 mg/L (high risk) (30).  
Lactation 
Each participant was assigned a lactation score in order to determine the duration 
and intensity of lactation. Every two weeks, participants in both groups were asked how 
they were feeding their infant. For every week since delivery, a participant was given a 
score of 2 if she was fully breastfeeding, a score of 1 if she was combining breastfeeding 
and formula feeding, and a score of 0 if she was fully formula feeding. The maximum 
score was 36 to 52 based on when the participant entered the study. The total score was 
divided by the maximum score to obtain the lactation score percentage. Women were 
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considered formula feeding if they had a score less than 25% of the maximum, low 
intensity, low duration breastfeeding with a score between 25-75% of the maximum, and 
high intensity, high duration breastfeeding with a score greater than 75% of the 
maximum.  
Statistical Analysis 
 Data was analyzed using JMP software (v.11.0.0, SAS Institute, Cary, NC). 
Student’s t-test and χ2 analysis were used to compare differences in baseline 
characteristics between groups for continuous and categorical variables respectively. 
Repeated measures ANOVA was used to test for time by group interactions, and main 
effects of time and group for anthropometrics, body composition, hs-CRP, lipids, 
glucose, insulin, and blood pressure between the intervention and control groups. 
Repeated measures analysis of covariance was used to test for significant differences in 
variables with lactation score percentage at endpoint and weeks postpartum at baseline 
used as covariates. Stepwise regression was used to determine independent predictors of 
change in biomarkers. Data are reported as mean (SEM), with significance set at p ≤ 
0.05.  
Results 
Thirty-four women were randomized to the intervention (n = 16) or control  
(n = 15) groups. Three women did not complete endpoint measurements due to a new 
pregnancy (n = 1) and lost to follow up (n = 2). Three women were excluded from the hs-
CRP analysis due to concentrations above 2 SD from the mean (> 13.6 mg/dL, range 22.5 
to 43.2 mg/dL) indicating likely acute inflammatory response. Additionally, the hs-CRP 
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concentrations were not normally distributed so natural log of these values was calculated 
and used for analysis.  
Baseline characteristics are reported in Chapter III (Table 3.1), and they did not 
differ between the intervention and control groups. Briefly, women at baseline were on 
average 31.3 ± 0.7 years of age, weighed 75.5 ± 1.6 kg, with a BMI of 27.8 ± 0.5 kg/m2. 
They were predominantly primiparous (65%) and breastfeeding at a high intensity and 
high duration (90%).  
Changes in weight, body composition, and cardiovascular fitness are presented in 
Chapter III (Table 3.2). Women in the intervention group had significantly greater 
reductions in weight (-3.8 ± 0.7 vs -1.8 ± 0.7 kg), BMI (-1.4 ± 0.2 vs. -0.7 ± 0.3 kg/m2), 
waist circumference (-4.4 ± 0.6 vs. -1.7 ± 0.6 cm), and trunk fat (-1.8 ± 0.4 vs. -0.7 ± 0.4 
kg) compared to the control group. There was a trend for greater reductions in fat mass in 
the intervention group (p = 0.052). The women in the intervention group also had a 
significant increase in VO2 max compared to a decrease in the control group.  
Metabolic Syndrome and Cardiometabolic Risk Factors 
 Changes in metabolic syndrome risk factors are presented in Table 4.1. The 
intervention group had greater reductions in waist circumference compared to the control 
group. While there was a trend for reduction in LDL cholesterol (p = 0.09) over time, 
there were no significant differences between groups for lipid profile (total cholesterol, 
LDL, HDL, triglycerides), insulin, glucose or blood pressure. However, after controlling 
for lactation duration and intensity at endpoint, there was a trend for significant 
differences in HOMA-IR between groups (p = 0.06), with the control group having a  
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Table 4.1. Metabolic Syndrome and Cardiovascular Risk Factors 
 Baseline Endpoint Change 
Metabolic Syndrome Criteria    
Waist circumference (cm)a    
       Intervention 86.5 (1.8) 82.1 (1.9) -4.4 (0.6) 
       Control 86.6 (1.9) 84.9 (2.0) -1.7 (0.6) 
Systolic BP (mmHg)    
       Intervention 111.1 (1.8) 108.8 (1.8) -2.3 (1.4) 
       Control 110.1 (1.8) 111.3 (2.8) 1.1 (2.5) 
Diastolic BP (mmHg)    
       Intervention 74.7 (1.9) 75.1 (1.7) 0.4 (2.2) 
       Control 72.6 (2.0) 72.2 (2.0) -0.4 (2.4) 
HDL cholesterol (mg/dL)    
       Intervention 54.3 (4.6) 48.1 (5.5) -6.2 (4.9) 
       Control 55.1 (4.8) 52.7 (5.6) -2.4 (3.9) 
Triglycerides (mg/dL)    
       Intervention 56.9 (5.8) 58.7 (6.5) -1.7 (6.6) 
       Control 65.4 (6.0) 77.8 (10.7) 12.4 (12.8) 
Fasting glucose (mg/dL)    
       Intervention 84.6 (3.9) 85.7 (4.2) 1.1 (3.6) 
       Control 87.1 (4.0) 93.9 (5.5) 6.8 (6.9) 
Other Risk Factors    
Total cholesterol (mg/dL)    
       Intervention 257.2 (12.3) 261.5 (14.2) 4.4 (14.5) 
       Control 264.5 (18.3) 263.0 (16.8) -1.5 (18.8) 
LDL cholesterol (mg/dL)    
       Intervention 115.4 (8.2) 108.1 (6.5) -7.3 (9.7) 
       Control 118.7 (8.4) 103.7 (9.2) -15.0 (8.3) 
Insulin (μU/mL)    
       Intervention 9.95 (1.31) 10.22 (1.16) 0.27 (0.63) 
       Control 9.75 (1.35) 11.03 (1.20) 1.3 (1.1) 
HOMA-IR (units)    
       Intervention 2.12 (0.33) 2.20 (0.30) 0.08 (0.20) 
       Control 2.20 (0.34) 2.62 (0.38) 0.42 (0.36) 
hs-CRP (mg/dL)    
       Intervention 2.78 (0.43) 3.19 (0.77) 0.41 (0.70) 
       Control 3.39 (0.82) 4.19 (1.1) 0.80 (0.58) 
BP, blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; HOMA-IR, 
homeostasis model assessment of insulin resistance; hs-CRP, high sensitivity C-reactive protein 
Data is mean (SEM). a p < 0.05
 
79 
greater increase in insulin resistance compared to the intervention group. After 
controlling for lactation percentage at endpoint and weeks postpartum at baseline, there 
was a significant difference in triglycerides between groups (p = 0.04), with a decrease in 
the intervention group and an increase in the control group. 
Table 4.2. C-Reactive Protein Risk Category at Baseline and Endpoint. 
 Baseline  Endpoint 
Low risk (< 1.0 mg/dL)    
     Intervention 2 (13%) 6 (40%) 
     Control 4 (31%) 4 (31%) 
Medium risk (1.0-2.9 mg/dL)   
     Intervention  6 (40%) 4 (27%) 
     Control 3 (23%) 0 (0%) 
High risk (> 3.0 mg/dL)   
     Intervention 7 (47%) 5 (33%) 
     Control 6 (46%) 9 (69%) 
Intervention n = 15 
Control n = 13 
There were no significant differences in hs-CRP by group or by time (Table 4.1). 
CRP risk categories are presented in Table 4.2. CRP risk category did not differ 
significantly at baseline. However, by endpoint, there was a significantly different 
distribution between groups with women in the control group being more likely to be in 
the high risk category (p = 0.04). Three participants in the intervention group reduced 
their risk from high to medium risk, while three women reduced their risk from medium 
to low risk. No intervention participants increased risk category. One participant in the 
control group reduced from medium to low risk. However, two participants increased 
from medium to high risk, and one participant increased from low to high risk. At 
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baseline, one participant from each group had greater than or equal to three criteria for 
diagnosis of metabolic syndrome (Table 4.3). By the end of the 12 week intervention, 
three women in the control group compared to one woman in the intervention group met 
the criteria for metabolic syndrome.  
A stepwise regression was conducted to determine predictors of change in 
cardiometabolic risk factors. The independent variables were change in weight, change in 
waist circumference, change in fat mass, change in fat free mass, change in VO2 max, 
group assignment (intervention or control), and weeks postpartum at baseline. Change in 
VO2 max (β = 0.37, p = 0.03), change in fat free mass (β = -0.43, p = 0.007), group 
assignment (β = -0.46, p = 0.0007), and triglycerides at baseline (β = -0.53, p = 0.002) 
were significant predictors of change in triglycerides (R2 = 0.44, p = 0.0001). Change in 
VO2 max (β = -0.05, p = 0.02) was a significant predictor of change in hs-CRP  
(R2 = 0.19, p = 0.03). While there were no independent predictors of total cholesterol, the 
model including change in BMI (β = 0.34, p = 0.48), change in percent fat mass 
(β = -0.11, p = 0.82), change in fat free mass (β = -0.04, p = 0.91), group assignment (β = 
013, p = 0.37), and total cholesterol at baseline (β = -0.72, p < 0.0001), was significant 
(R2 = 0.46, p = 0.007). Endpoint lactation score percentage (β = -0.42, p = 0.01) and 
baseline HOMA-IR (β = -0.35, p = 0.02) were significant predictors of change in 
HOMA-IR (R2 = 0.58, p = 0.004). There were no significant predictors of change in, 
LDL, HDL, systolic or diastolic blood pressure, glucose, and insulin.  
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Table 4.3. Number of Participants Meeting Metabolic Syndrome Risk Criteria  
  Baseline Endpoint 
Waist Circumference (>88 cm)    
     Intervention  7 (44%) 3 (19%) 
     Control  7 (47%) 5 (33%) 
Fasting Glucose (>100 mg/dL)    
     Intervention  1 (6%) 3 (19%) 
     Control  4 (27%) 6 (37%) 
Blood Pressure (>130/85 
mmHg) 
   
     Intervention  2 (13%) 1 (6%) 
     Control  1 (7%) 0 (0%) 
HDL Cholesterol (<50 mg/dL)    
     Intervention  8 (50%) 10 (63%) 
     Control  10 (67%) 11 (73%) 
Triglycerides (>150 mg/dL)    
     Intervention  0 (0%) 0 (0%) 
     Control  0 (0%) 1 (7%) 
0 MetSyn Criteria    
     Intervention  4 (25%) 4 (25%) 
     Control  3 (20%) 2 (13%) 
1 MetSyn Criteria    
     Intervention  7 (44%) 9 (56%) 
     Control  3 (20%) 5 (33%) 
2 MetSyn Criteria    
     Intervention  4 (25%) 2 (13%) 
     Control  8 (52%) 5 (33%) 
≥ 3 MetSyn Criteria    
     Intervention  1 (6%) 1 (6%) 
     Control  1 (7%) 3 (20%) 
Data are number of participants meeting criteria (percentage). 
Discussion 
This study found that a diet and exercise intervention resulted in significant 
weight loss and loss of abdominal obesity in postpartum women. After controlling for 
lactation status and weeks postpartum at the start of the study, the intervention group had 
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greater reductions in insulin resistance and triglycerides compared to the control group. 
However, other metabolic risk factors were not impacted by the intervention.  
Previous studies have found conflicting results. In two studies examining the 
impact of exercise only on cardiovascular risk factors, no differences in lipid profile 
between groups was observed (21, 22). However, while Lovelady et al found no effect of 
exercise on insulin and glucose response to a test meal, they did find a significant 
negative association between change in VO2 max and change in insulin response (21). 
Women in these groups were normal weight at the start of the intervention and weight 
loss was modest. Studies that have combined exercise with an energy restriction have 
found a greater impact on these risk factors. Davenport et al found a significant reduction 
in waist circumference, fasting glucose, and LDL cholesterol as a result of a diet and 
exercise intervention (23). Additionally, Brekke et al found a significant effect of diet on 
waist circumference, total cholesterol, LDL, and insulin after a 12 week intervention (24). 
Weight loss in these studies was significantly greater than in the present study. The 
weight loss achieved in this study may not have been adequate to observe significant 
differences between groups.  
 We did not observe significant differences in hs-CRP between groups. This is a 
similar finding to Brekke et al, who found no effect of diet or exercise on hs-CRP, IL-6, 
or TNF-α (24). Another study by Stendell-Hollis found a significant reduction in TNF-α 
following either a Mediterranean or MyPyramid diet in postpartum women, but 
differences were not significant between groups (25). This may reflect a natural reduction 
in CRP during the postpartum period. Inflammation is heightened during pregnancy (11-
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15), and remains elevated in the early postpartum period (31). Furthermore, weight loss 
of at least 10% may be required to observe changes in inflammation (32). Weight loss in 
the intervention group for this study was only 5%. Despite lack of change in CRP in the 
intervention group, we did observe a reduction in cardiovascular risk with more women 
in the intervention group moving to a lower CRP risk category compared to the control 
group. We also observed that changes in VO2 max were negatively associated with 
changes in CRP, suggesting that improving aerobic fitness may be beneficial for reducing 
systemic inflammation. Other studies have found similar associations between VO2 max 
and CRP in women (33-35).  
 Overweight and obese, postpartum women are at risk of metabolic syndrome. In 
this study, two women (6.6%) met the criteria for metabolic syndrome at baseline, while 
four women met the criteria at endpoint (12.9%). Another 12 women (39%) had two risk 
factors for metabolic syndrome at baseline. In these participants, high waist 
circumference and low HDL were the most frequent abnormal values. This is similar to a 
study of 68 lactating Swedish women, which found that 6.2% of participants were 
classified as having the metabolic syndrome, meeting the criteria with high waist 
circumference and blood pressure and low HDL (36). Weight loss interventions are 
important for reducing the risk factors in this population as childbearing is associated 
with an increased risk of metabolic syndrome later in life (18).  
Strengths of this study include the randomized, controlled design and the low 
participant attrition rate. Additionally, few studies have examined the impact of a weight 
loss intervention on metabolic syndrome and inflammation in postpartum women. 
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Limitations include the relatively small sample size, and weight loss that, while 
significant, was modest. However, the strategies utilized in the intervention were 
designed to conform to the time constraints of caring for a new infant. A study of longer 
duration or a longer follow up may have yielded better results. Additionally, changes in 
cardiovascular fitness were associated with changes in CRP. Incorporation of a more 
intense exercise regimen into a weight loss intervention may help reduce cardiometabolic 
risk factors further. The participants in this study were eligible to participate between 6 
and 14 weeks postpartum. Lipid levels typically return to pre-pregnancy levels by around 
6 weeks postpartum (8). However, these levels may have still been elevated in women 
who started the intervention earlier. Finally, most women (90%) were high intensity, high 
duration breastfeeding at the start of the intervention, but some woman began formula 
feeding by the end of the study. Since lactation may help women return to pre-pregnancy 
concentrations of lipids, glucose, and insulin earlier (9, 10, 19), this change in lactation 
status may have impacted the results of the study.  
In conclusion, overweight and obese, postpartum women are at an increased risk 
of developing chronic disease later in life (18). The postpartum period is an optimal time 
to intervene to reduce a woman’s risk factors. In this study, we found that a 12 week, 
home-based, diet and exercise intervention was successful in reducing weight and 
abdominal obesity, as well as improving triglyceride and insulin resistance in postpartum 
women. 
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CHAPTER V 
 
ASSOCIATION BETWEEN AEROBIC FITNESS AND INFLAMMATION WITH 
BONE MINERAL DENSITY IN LACTATING WOMEN AFTER A WEIGHT 
LOSS PROGRAM 
     Formatted for publication in Medicine and Science in Sports and Exercise 
Introduction 
Obesity increases a person’s risk for chronic disease, such as heart disease and 
diabetes. This is especially an issue among women of childbearing age, with 55.8% of 
women between the ages of 20 and 39 years being overweight or obese (1). While obesity 
has been shown to be associated with higher bone mineral density (BMD) (2), weight 
loss may increase bone turnover and decrease BMD, particularly at trabecular-rich sites 
(lumbar spine and total hip) (2). Some researchers have reported decreases in BMD with 
moderate (3) and rapid (4, 5) weight loss in overweight and obese premenopausal 
women. However, other studies have not observed bone loss with weight loss (6-8).  
This loss of BMD is of concern during weight loss in the postpartum period 
because lactation is also associated with a decrease in BMD, with reported bone losses of 
1 to 3% per month (9), up to a total of 9% at trabecular-rich sites (10). This initial rapid 
bone loss is thought to be due to increased concentrations of prolactin during early 
lactation (11). Bone loss slows after 3 to 4 months postpartum as prolactin concentrations 
decrease (11, 12) or after the return of menses (13). After weaning or after the return of 
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menses, BMD returns to baseline levels within 12 to 18 months postpartum (14). 
However, it is unclear if weight loss during this time exacerbates BMD loss.  
 Exercise has been shown to attenuate this bone loss in postmenopausal women. 
Increased maximal oxygen uptake (VO2 max) has been found to be associated with 
increased total body (15), femoral neck (16), and leg BMD (17). Another study by 
Silverman et al found a positive relationship between VO2 max and femoral neck BMD 
after a 6 month weight loss program in overweight postmenopausal women (18). 
However, in other reports, the addition of aerobic (19, 20) or resistance exercise (21) to a 
weight loss program in overweight and obese premenopausal women did not have an 
impact on BMD changes.  
 Exercise may also reduce BMD losses during lactation. Lovelady et al examined 
the impact of a resistance and aerobic exercise intervention on BMD in lactating women 
(22). Compared to women in the control group, women in the intervention group had less 
bone loss at the lumbar spine after the 16 week intervention. While energy restriction was 
not a component of the intervention, both groups lost a similar amount of weight. 
Colleran et al investigated the effect of a resistance exercise combined with energy 
restriction on BMD in overweight and obese fully breastfeeding women (23). The 
exercise and control groups had similar reductions in BMD. However, the intervention 
group lost more weight, suggesting that resistance exercise may be protective against 
reductions in BMD during weight loss in lactating women. Two other studies found 
losses of lumbar spine and femoral neck BMD in exercising women were similar to  
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non-exercising controls (24, 25). However, these studies did not involve a structured, 
randomized exercise intervention and the women were within a normal BMI range. The 
effect of aerobic exercise with energy restriction on BMD has not been well studied in 
postpartum women.   
In addition to its impact on BMD, obesity is associated with elevated levels of 
inflammatory cytokines, such interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), 
and C-reactive protein (CRP) (26), which are also involved in bone remodeling (27, 28). 
However, it is unknown if inflammation associated with obesity exacerbates bone loss in 
breastfeeding women or inhibits the gains observed after weaning. Several studies in 
postmenopausal women found an association between IL-6, CRP, and TNF-α and total 
body and regional BMD (29-33). However, others report no significant correlations 
between inflammatory cytokines and BMD (33, 34).  
Few studies examining this relationship in premenopausal women have been 
conducted. Salamone et al found a negative relationship between TNF-α and IL-6 with 
femoral neck and lumbar spine BMD (35). Others have found a similar relationship with 
CRP and BMD in premenopausal women (36, 37). However, two studies found no 
significant relationship between CRP and BMD (31, 38). Few studies have investigated 
this relationship during weight loss. Silverman et al found that change in TNF receptor 1 
was positively associated with change in femoral neck BMD after weight loss in obese 
postmenopausal women (18). Labouesse et al reported that 20% of the variance in post-
weight loss hip BMD was explained by a combination of inflammatory, endocrine, and 
anthropometric variables (39).  
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 While these studies suggest that exercise may reduce bone loss observed during a 
weight loss intervention, results from previous studies are inconsistent. However, few 
studies have looked at the effect of aerobic exercise on BMD in lactating women. 
Elevated inflammation in overweight lactating women may also exacerbate this bone 
loss, but this relationship has not been studied in this population. Therefore, the purpose 
of this study is to examine the relationship between aerobic exercise, CRP, and BMD, 
and determine if improvements in cardiovascular fitness and reductions in CRP as a 
result of a weight loss intervention attenuates the loss of BMD in lactating women.  
Methods 
Study Participants 
Women were recruited from the Greensboro, NC community at pre- and postnatal 
classes. Flyers were also posted in local obstetrician and pediatric offices. Eligibility 
criteria include, 1) 6 to 14 weeks postpartum with singleton birth, 2) self-reported BMI 
between 25 and 35 kg/m2 or at least 4.5 kg heavier than pre-pregnancy weight, 3) 18 
years and older, 4) sedentary (physical activity less than 3 days per week, 5) free of 
chronic disease, and 6) non-smokers. Women who had a cesarean section were not 
excluded from the study, but they did not start the intervention until 14 weeks 
postpartum. All participants returned a medical clearance form from their physician at 
baseline clearing them to participate in a diet and exercise intervention. The original 
study was powered to detect a 2.0 kg change in weight (sample size of 12 per group) with 
80% power and a 2-sided alpha of 0.05. However, it was not powered to detect change in 
BMD.  
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Study Design 
The study was designed to examine the effects of a home-based, self-monitoring 
diet and exercise intervention on changes in weight and body composition. Participants 
were randomized, stratified based on BMI and time from childbirth into either the diet 
and exercise intervention or control group. The study was approved by the Institutional 
Review Board at the University of North Carolina Greensboro.  
Study Intervention 
The intervention consisted of a 12-week diet and exercise program with 
participants eligible to begin between 6 to 14 weeks postpartum. The intervention 
involved self-monitoring of dietary intake and physical activity, with guidance provided 
by a registered dietitian (RD). Individualized energy prescriptions with sample meal 
plans were provided to participants at the beginning of the intervention. Energy needs 
were calculated using the National Academy of Sciences/Institute of Medicine energy 
expenditure equation (40). An energy reduction of 500 kcal/day was added in order to 
promote a 0.5 kg/week weight loss. Women who were fully breastfeeding were allowed 
an additional 330 kcal/day, while women who were mixed feeding (breastfeeding and 
formula) were allowed an additional 150 kcal/day.  
The exercise component of the intervention involved increasing aerobic exercise. 
Participants were asked to wear a pedometer (Omron Healthcare, Inc., Lake Forest, IL) 
every day, and record daily steps and aerobic steps. A goal of 10,000 steps daily was set, 
with instructions to increase amounts by 1,000 steps every week. Participants were given 
a secondary goal of achieving 3,000 aerobic steps daily, which is the equivalent of 30 
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minutes of moderate activity (41). Aerobic steps are calculated when a participant walks 
at least 100 steps per minute for at least 10 minutes.  
The control group was instructed to not change diet or exercise habits for the 
duration of the study. All participants were contacted biweekly by telephone or email. 
Laboratory Measurements 
 Measurements, including anthropometrics, bone density and bone mineral content 
(BMC), body composition, cardiovascular fitness, and inflammatory proteins, were taken 
at baseline (6 to 14 weeks postpartum) and after the 12 week intervention (18 to 26 weeks 
postpartum).  
 Body Composition. Height and weight were measured using a digital stadiometer 
(235 Heightronic Digital Stadiometer, Snoqualmie, WA) and a calibrated digital scale 
(Tanita BWB-800S). Body composition, BMD, and BMC were measured using whole 
body dual-energy x-ray absorptiometry (DXA: Lunar Prodigy Advance, GE Healthcare, 
Madison, WI, QDR enCORE 2011 software version 13.60) by a trained DXA technician. 
Participants lied flat and still in the supine position on the x-ray table. The fan-bean 
scanner scanned the whole body from head to toe with a series of transverse scans. Body 
composition measurements included fat mass, lean mass, and trunk fat mass. Lean mass 
was calculated as fat-free mass, excluding BMC. Trunk fat was calculated as the amount 
of fat located in the neck, chest, abdominal, and pelvic regions. BMD and BMC were 
measured for total body, lumbar spine (L1-L4), and the total hip, including the femoral 
neck. A pregnancy test was conducted prior to DXA scan using an early pregnancy test, 
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which detects human chorionic gonadotropin at levels of 20 mIU/mL. This was to ensure 
that the participant was not pregnant at the time of DXA scan.  
 Inflammatory Markers. Participants were instructed to not take anti-
inflammatory medications the day before and morning of the intitial visit. Initial 
assessment was rescheduled if a participant was ill or taking anti-inflammatory 
medications as these may alter inflammatory protein concentrations. Blood was drawn 
after an overnight fast by a trained phlebotomist using standard procedures. Vacutainers 
were left at room temperature for 20 minutes to allow the blood to clot. Samples were 
spun in a centrifuge at 3000 rpm at 4°C for 30 minutes. Serum was aliquoted into micro-
centrifuge tubes and stored at -80°C until analyzed. ELISA kits were used to determine 
concentrations of high sensitivity CRP (hs-CRP: Genway Biotech, Inc., San Diego, CA).  
 Cardiovascular Fitness. Cardiovascular fitness was determined by submaximal 
treadmill testing using a modified Balke protocol test (42). Resting heart rate (RHR) was 
determined using a heart rate (HR) monitor (Polar, Inc., Woodbury, NY) worn by 
participants throughout the testing. Participants warmed up on the treadmill for three 
minutes, then the speed was increased to a brisk, slightly uncomfortable speed, which 
remained consistent throughout the testing. Participants either walked (< 3.7 mph) or a 
jogged (> 3.7 mph). The initial incline was 0% and was increased by 2.5% every three 
minutes. HR and perceived exertion were recorded every minute during the test. The test 
continued until the participant’s HR reached 85% of their predicted maximum HR or if 
the participant asked to stop. Maximum HR was determined using the heart rate reserve 
(HRR) formula [HRR = (220-age-RHR) x 0.85 + RHR]. A linear regression model was 
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used to calculate predicted VO2 max (independent variable = HR, dependent variable = 
predicted VO2) (42).  
Dietary Intake 
 Two 24-hour dietary recalls were collected by telephone or in person within the 
same week as baseline measurement using the Minnesota Nutrition Data System for 
Research (NDSR, Nutrition Coordinating Center, University of Minnesota, MN) 
software. Efforts were made to include one weekend day, but this was not always 
achieved due to participant scheduling.. This program utilizes a multipass method in 
order to accurately record dietary intake. Information on supplement use in the previous 
24 hours was also obtained. Calcium intake was determined using these dietary records. 
A 4 day average calcium intake was calculated using two recalls at baseline and two 
recalls at endpoint.  
Lactation 
Every two weeks, participants in both groups were asked about their infant 
feeding practices. A lactation score was calculated for all participants in order to quantify 
the intensity and duration of breastfeeding. A score of 2 was assigned for every week a 
woman was fully breastfeeding, a score of 1 for mixed feeding (breastfeeding and 
formula feeding), and a score of 0 for fully formula feeding. A maximum score of 36 to 
52 was assigned depending on when the participant entered the study. Percentage of the 
maximum score was calculated at baseline and endpoint by dividing the lactation score 
by the maximum possible score for fully breastfeeding. Women were categorized as high 
duration, high intensity breastfeeding if they had a score greater than 75% of the 
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maximum score. They were categorized as formula feeding if they had a score less than 
25% of the maximum. Women with scores between 25-75% of the maximum score were 
categorized as low intensity, low duration breastfeeding.  
Statistical Analysis 
 Data was analyzed using JMP software (v.11.0.0, SAS Institute, Cary, NC). 
Student’s t-test and χ2 analysis were used to compare differences in baseline 
characteristics between the intervention and control groups. Repeated measures analysis 
of covariance was used to determine differences in total body, lumbar spine, total hip, 
and femoral neck BMD and BMC between the intervention and control group over time 
with endpoint lactation score percentage and weeks postpartum at baseline as covariates. 
Pearson’s correlations coefficients were used to determine the relationship between 
baseline and endpoint values of total body, lumbar spine, total hip, and femoral neck 
BMD and BMC with baseline and endpoint body weight and composition, VO2 max, hs-
CRP, lactation score percentage, and average calcium intake. Correlations were also used 
to determine the relationship between changes in BMD and BMC and the above 
variables. These analyses were used to determine variables included in the multiple 
regression models. Stepwise regression was used to determine the independent predictors 
of change in total body, lumbar spine, total hip, and femoral neck BMD and BMC. Data 
are reported as mean ± SEM, with significance set at p ≤ 0.05.  
Results 
 Thirty-four women were randomized to either the intervention group (n = 17) or 
control group (n = 17). Three participants dropped out of the study (1 from intervention, 
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2 from control) due to pregnancy and lost to follow up. Additionally, three women had 
endpoint CRP levels greater than 17.6 mg/dL (two SD from the mean), indicating a high 
likelihood of acute inflammatory response. These values were excluded from the 
analysis. Since hs-CRP concentrations were not normally distributed, the natural log of 
these values was used for analysis. Baseline criteria are presented in Chapter III (Table 
3.1). There were no significant differences between groups at baseline. Women were an 
average age of 31.3 ± 0.7 years. They weighed a mean of 75.5 ± 1.6 kg and had a mean 
BMI of 27.8 ± 0.5 kg/m2. On average, participants were 11.6 ± 0.5 weeks postpartum.  
 The intervention group lost significantly more weight and had significantly 
greater reductions in BMI than the control group. There was a trend for greater reductions 
in percent body fat (P = 0.08) and total fat mass (P = 0.05) in the intervention group. 
There were no changes in lean mass in either group. Predicted VO2 max improved by  
9.3 ± 3.5% for the intervention group, while decreasing by 5.3 ± 5.6% in the control 
group (P = 0.03). These data are presented in Table 5.1. 
 There were significant reductions in lumbar spine hip and femoral neck BMD in 
both groups over time, and significant reductions in total body, lumbar spine, hip, and 
femoral neck BMC (Table 5.2). However, there were no significant time by group 
interactions for total body BMD or BMC. However, after controlling for lactation score 
percentage at endpoint and weeks postpartum at baseline, there was a significant 
difference between groups in total body BMD (P = 0.02), total hip BMD (P = 0.01) and 
BMC (P = 0.003), lumbar spine BMC (P = 0.01), and femoral neck BMC (P = 0.02).  
There was a trend for significant differences between groups for femoral neck BMD  
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Table 5.1. Body Composition and CRP at Baseline and Endpoint after the Intervention. 
  Intervention    Control  
 Baseline Endpoint Change  Baseline Endpoint Change 
Weight (kg)a 76.7 (2.2) 72.9 (2.4) -3.8 (0.7)  74.2 (2.3) 72.3 (2.7) -1.8 (0.7) 
BMI (kg/m2)a 28.4 (0.7) 27.0 (0.8) -1.4 (0.2)  27.1 (0.8) 26.5 (0.9) -0.7 (0.3) 
Fat mass (kg) 32.2 (1.7) 28.6 (1.7) -3.5 (0.6)  30.3 (1.8) 28.6 (2.1) -1.8 (0.6) 
Lean mass (kg) 41.9 (0.9) 41.7 (1.0) -0.2 (0.3)  41.2 (1.0) 41.2 (1.1) 0.0 (0.3) 
% Body fat (%) 41.7 (1.2) 38.9 (1.3) -2.8 (0.5)  40.5 (1.3) 39.0 (1.5) -1.4 (0.6) 
Trunk fat (kg)a 16.0 (1.0) 14.2 (1.1) -1.8 (0.4)  15.6 (1.0) 14.9 (1.2) -0.7 (0.4) 
VO2 max (mL/kg/min)a  30.6 (1.3) 33.2 (1.4) 2.6 (1.0)  31.1 (1.4) 29.2 (1.9) -1.9 (1.7) 
Calcium intake (mg)* 1405 (151) 1273 (146) -132 (136)  1247 (103) 1350 (110) 103 (140) 
hs-CRP (mg/L) 2.78 (0.43) 3.19 (0.77) 0.41 (0.70)  3.39 (0.82) 4.19 (1.1) 0.80 (0.58) 
Values are mean (SEM). 
BMI, body mass index; VO2 max, maximal oxygen uptake; hs-CRP, high sensitivity C-reactive protein 
* Calcium intake includes intake from supplements.  
Significant time by group interaction: a P < 0.05.
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Table 5.2. BMD and CRP at Baseline and Endpoint and Change after the Intervention.  
  Intervention    Control  
 Baseline Endpoint Change  Baseline Endpoint Change 
Total Body         
    BMD (g/cm2)a 1.187 (0.020) 1.179 (0.012) -0.01 (0.004)  1.198 (0.021) 1.194 (0.027) -0.004 (0.005) 
    BMC (g) 2644 (84) 2579 (66) -65 (15)  2615 (87) 2591 (96) -24 (15) 
LS BMD (g/cm2)        
    BMD (g/cm2) 1.225 (0.031) 1.198 (0.025) -0.027 (0.010)  1.229 (0.032) 1.205 (0.040) -0.024 (0.010) 
    BMC (g)a 66 (3) 64 (2) -2 (1)  66 (3) 66 (2) 0 (1) 
Hip BMD (g/cm2)        
    BMD (g/cm2)a 1.037 (0.027) 1.018 (0.019) -0.018 (0.006)  1.020 (0.027) 1.003 (0.030) -0.017 (0.007) 
    BMC (g)a 32 (1) 31 (1) -1 (0.2)  31 (1) 30 (1) -1 (0.2) 
FN BMD (g/cm2)        
    BMD (g/cm2) 1.038 (0.024) 1.021 (0.021) -0.017 (0.006)  1.018 (0.025) 0.994 (0.023) -0.028 (0.007) 
    BMC (g)a 4.9 (0.2) 4.8 (0.1) -0.1 (0.04)  4.8 (0.2) 4.7 (0.1) -0.1 (0.03) 
Data are mean (SEM) 
BMD, bone mineral density; BMC, bone mineral content; LS, lumbar spine; Hip, total hip; FN, femoral neck 
Significant time by group interaction controlling for lactation score percentage at endpoint and weeks postpartum at baseline; 
ANCOVA: a P < 0.05. 
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(P = 0.06). The intervention attenuated bone loss after controlling for lactation status and 
weeks postpartum at baseline. 
Predictors of Change in Bone Mineral Density 
 Bivariate correlation data are presented in Appendix A. At baseline, lean body 
mass was significantly positively correlated with total body BMD and BMC, lumbar 
spine BMD and BMC, total hip BMC, and femoral neck BMC. VO2 max at baseline was 
positively associated with total hip BMC, and tended to be positively correlated with total 
hip (P = 0.05) and femoral neck (P = 0.06) BMD and femoral neck BMC (P = 0.05). 
Lactation score percentage at baseline was negatively correlated with lumbar spine BMD. 
Weight at baseline was positively associated with total body BMC.  
 At endpoint, lean mass was significantly correlated with total body BMD and 
lumbar spine, total hip, and femoral neck BMC. VO2 max was positively correlated with 
total hip and femoral neck BMC. There was a trend for positive correlation of VO2 max 
(P = 0.07) and negative correlation between hs-CRP (P  = 0.09) and fat mass (P  = 0.09) 
with femoral neck BMD. Endpoint hs-CRP was negatively correlated with endpoint 
femoral neck BMC. Endpoint weight was positively correlated with endpoint total body 
BMC.  
 Lactation score percentage was negatively associated with change in total body, 
total hip and lumbar spine BMD. Change in lean mass (P = 0.09) tended to be positively 
associated with change in total body BMD, while change in hs-CRP (P = 0.06) and 4 day 
calcium average (P = 0.08) tended to be negatively associated. Change in VO2 max 
tended to be positively correlated with changes in femoral neck BMD (P = 0.09). Change 
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in fat mass was positively associated with change in total body BMC, while change in 
lean mass and endpoint lactation score percentage were negatively associated. Lactation 
score percentage was negatively associated with total hip BMC, while change in VO2 
max tended to be positively associated with change in femoral neck BMC (P = 0.09).  
 Stepwise regression models were run to determine predictors of change in total 
body, lumbar spine, total hip, and femoral neck BMD and BMC, controlling for endpoint 
lactation score percentage, baseline lean mass, and baseline values for total body, lumbar 
spine, total hip, and femoral neck BMD and BMC. The independent variables entered 
into the models were change in weight, change in VO2 max, change in hs-CRP, and 4 day 
calcium intake average. Since change in weight and change in fat mass were highly 
correlated (r = 0.93, P <0.001), only change in weight was entered into the model.  
 Results of the multiple regression analysis are presented in Table 5.3 and 5.4. 
When controlling for lactation score percentage, baseline lean mass, and baseline total 
body BMD, change in hs-CRP was a significant predictor of change in total body BMD 
(R2 = 0.51, P = 0.003). Reductions in hs-CRP predicted an increase in total body BMD. 
Change in VO2 max was a significant predictor of change in total hip (R
2 = 0.48, P = 
0.002) and femoral neck BMD (R2 = 0.42, P =0.01). An increase in VO2 max predicted 
an increase in total hip and femoral neck BMD. There were no significant predictors of 
change in lumbar spine BMD when controlling for lactation score percentage, baseline 
lean mass, and baseline lumbar spine BMD.   
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Table 5.3. Stepwise Regression Models for Change in BMD. 
 Δ TB BMD (g/cm2)  
 
Δ LS BMD (g/cm2) Δ Hip BMD (g/cm2) Δ FN BMD (g/cm2) 
Intercept 0.136 (0.042)b 0.071 (0.104) 0.099 (0.056) 0.073 (0.063) 
Predictors*:     
    Change in weight (kg) - - - -0.004 (0.02) 
    Change in hs-CRP (mg/L) -0.012 (0.003)b - - - 
    Change in  VO2 max (L/min) - -0.003 (0.002) -0.003 (0.001)a 0.003 (0.001)a 
     
Covariates:     
    Lactation score percentage -0.0002 (0.0001) -0.0006 (0.0003) -0.0005 (0.0002)a -0.0003 (0.0002) 
    Baseline lean mass (kg) -8.85E-7 (7.58E-7) -2.34E-6 (2.18E-6) 1.05E-6 (1.13E-6) 1.63E-6 (1.37E-6) 
    Baseline TB BMD (g/cm2) -0.073 (0.039)  - - 
    Baseline LS BMD (g/cm2) - 0.045 (0.079) - - 
    Baseline Hip BMD (g/cm2) - - -0.123 (0.048)a - 
    Baseline FN BMD (g/cm2) - - - -0.145 (0.052)a 
BMD = bone mineral density; TB = total body; LS = lumbar spine; FN = femoral neck; hs-CRP = high sensitivity C-reactive protein. 
 
Data are β coefficient (SEM) 
Results are shown only for variables with p < 0.1 for final model; Significant effects in bold: a p < 0.05, b .p < 0.01 
 
* Predictor reference values are means of total sample (n = 31): Change in weight = -2.9 kg; Change in hs-CRP = 0.59 mg/L; Change in VO2 max = 1.17 
L/min; Lactation score percentage = 86.2%; Baseline lean mass = 41.6 kg; Baseline TB BMD = 1.192 g/cm2; Baseline LS BMD = 1.227 g/cm2; 
Baseline Hip BMD = 1.029 g/cm2; Baseline FN BMD = 1.028 g/cm2
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Table 5.4. Stepwise Regression Models for Change in BMC 
 Δ TB BMC (g) Δ LS BMC (g)  Δ Hip BMC (g) Δ FN BMC (g) 
Intercept 230.7 (227.2) 19.52 (7.92)a 2.12 (1.50) 0.592 (0.301) 
Predictors*:     
    Change in weight (kg) - - - - 
    Change in hs-CRP (mg/L) - - - - 
    Change in VO2 max (L/min) - - - 0.019 (0.007)a 
     
Covariates:     
    Lactation score percentage -1.789 (0.715)a -0.0.61 (0.029)a -0.014 (0.010) -0.002 (0.001) 
    Baseline lean mass (kg) -0.002 (0.005) -0.0002 (0.0002) 5.24E-5 (4.26E-5) 5.37E-6 (7.88E-6) 
    Baseline TB BMC (g/cm2) -0.014 (0.064) - - - 
    Baseline LS BMC (g/cm2) - -0.129 (0.087) - - 
    Baseline Hip BMC (g/cm2) - - -0.128 (0.042)b - 
    Baseline FN BMC (g/cm2) - - - -0.165 (0.051)b 
BMC = bone mineral content; TB = total body; LS = lumbar spine; FN = femoral neck; hs-CRP = high sensitivity C-reactive protein. 
 
Data are β coefficient (SEM) 
Results are shown only for variables with p < 0.1 for final model; Significant effects in bold: a p < 0.05, b .p < 0.01 
 
* Predictor reference values are means of total sample (n = 31): Change in weight = -2.9 kg; Change in hs-CRP = 0.59 mg/L; Change in VO2 max = 1.17 
L/min; Lactation score percentage = 86.2%; Baseline lean mass = 41.6 kg; Baseline TB BMC = 2.63 g/cm2; Baseline LS BMC = 66.12 g/cm2; Baseline 
Hip BMC = 31.25 g/cm2; Baseline FN BMC = 4.82 g/cm2. 
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 When controlling for lactation score percentage, baseline lean mass, and baseline 
femoral neck BMC, change in VO2 max was a significant predictor of change in femoral 
neck BMC (R2 = 0.47, P = 0.002). An increase in VO2 max resulted in an increase in 
femoral neck BMC. There were no significant predictors of total body, lumbar spine, or 
total hip BMC when controlling for lactation score percentage, baseline lean mass, and 
baseline values of total body, lumbar spine, and total hip BMC. 
Discussion 
 Over the 12-week diet and exercise intervention, the intervention group lost 
significantly more weight than the control group, with a trend for a greater decrease in fat 
mass. Cardiovascular fitness levels, as measured by VO2 max, increased significantly in 
the intervention group, compared to a decrease in the control group. While both groups 
had significant decreases in lumber spine, total hip, and femoral neck BMD and total 
body, total hip, and femoral neck BMC over time, there were no significant differences 
between groups. However, when controlling for lactation score percentage at endpoint 
and weeks postpartum at baseline, there were significant differences between groups for 
total body and  total hip BMD, and lumbar spine, total hip, and femoral neck BMC.  
 We found that an increase in maximal oxygen uptake was associated with an 
increase in total hip and femoral neck BMD and BMC, suggesting that the improvement 
in aerobic fitness observed in the intervention group may be responsible for the 
attenuation of bone loss. Other studies have observed a positive relationship between 
VO2 max and BMD at the total body (12), femoral neck (16) and legs (17) in 
postmenopausal women. Another study by Ryan et al in postmenopausal women found 
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that the addition of aerobic exercise to a 6 month weight loss intervention prevented bone 
loss at the femoral neck, Ward’s triangle, and greater trochanter (43). A study by 
Silverman et al found that after this same intervention, there was a positive relationship 
between VO2 max and femoral neck BMD (18). However, other studies in 
premenopausal women failed to detect a difference in BMD during weight loss when 
walking, running, or cycling was added to the dietary intervention (19, 20).  
Since breastfeeding is associated with increased bone loss of 1 to 3% per month 
(9) with losses up to 9% at trabecular-rich sites, such as the lumbar spine and hip (10), 
aerobic exercise may be protective against bone loss during weight loss in the postpartum 
period. In contrast to our findings, a study Clapp and Little found that regular, self-
selected exercise during the first three months of the postpartum period had no impact on 
total body, lumbar spine, or femoral neck BMD in lactating women despite higher 
preconception VO2 max compared to a sedentary control group (25). In contrast to this, 
Lovelady et al found that breastfeeding women randomized to a 16-week aerobic and 
resistance exercise group had smaller reductions in lumbar spine BMD compared to a 
control group (-4.8% vs. -7.0%) (12). However, weight loss was not a target in either of 
these studies. Colleran et al examined the effect of a 16-week energy restriction and 
resistance exercise program on BMD in overweight and obese, fully breastfeeding 
women (23). While women in the resistance exercise group had similar BMD losses 
compared to the control group, they had significantly higher weight loss, suggesting that 
resistance exercise may protect against additional bone loss during weight loss in 
lactating women.  
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 In this study, we did not observe significant differences between groups in hs-
CRP concentrations. However, change in hs-CRP was found to be a significant predictor 
of change in BMD in a multivariate regression model. Weight loss has been shown to 
reduce inflammation in overweight and obese adults (44). However, its relationship to 
bone loss during weight loss has not been well studied. Silverman et al found that change 
in TNF-α receptor, another marker of systemic inflammation, after a weight loss 
intervention was negatively correlated with change in femoral neck BMD in 
postmenopausal women (18). Labouesse et al found that after weight loss, there was a 
negative association between markers of bone turnover and inflammatory proteins  
(TNF-α, IL-1β, and CRP) (39). Their study also found that 20% of the variance in post-
weight loss hip BMD was explained by inflammatory, endocrine, and anthropometric 
variables.  
 Interestingly, we did not observe a significant relationship between calcium intake 
and BMD. Calcium intake tended to be significantly associated with change in total body 
BMD, but was not found to be a significant predictor of change in total body lumbar 
spine, total hip, or femoral neck BMD when controlling for lactation status, baseline lean 
mass, and baseline BMD. However, average calcium intake in both groups met 
recommendations for calcium intake for lactating women, with an average intake of 
1,329 mg daily (range 644 to 2136 mg) with 21 participants (68%) consuming over 900 
mg of calcium daily. Previous studies have found that calcium intakes above 1,000 mg 
daily were protective of BMD during weight loss, but higher intakes did not have 
additional benefits on BMD (8).  
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 This study was not powered to detect an association between CRP and BMD, and 
weight loss observed in the intervention group may not have been adequate to induce 
significant reductions in CRP. Also, there were more women who stopped fully 
breastfeeding in the control group. While the effect of lactation on CRP concentrations 
during the postpartum period remains unclear, the lactation status of participants in this 
study may have impacted changes in CRP as a result of the intervention. Additionally, the 
exercise intensity may not have been adequate to fully attenuate bone loss. A more 
intense exercise regime or one that incorporates aerobic and resistance exercise may be 
more beneficial in improving CRP and attenuating bone loss. However, the exercise 
regimen in this study was designed to be time-saving and practical considering the time 
constraints of caring for an infant. Additionally, the duration of the study (12 weeks) may 
not have been adequate to observe changes in BMD. During lactation, the rate of bone 
turnover is increased, with a full cycle occurring over 3 to 4 months (10). A longer study 
of at least 16-weeks may be needed to detect the effects of exercise on BMD.  
 This study is the first to our knowledge to report on the relationship between 
CRP, cardiovascular fitness, and BMD in lactating women. Future research should focus 
on interventions of a longer duration with a more intense aerobic exercise regimen. The 
combination of aerobic and resistance exercise may have a stronger impact on BMD. 
Additionally, studies comparing changes in BMD during weight loss with and without 
exercise in lactating women are needed.  
 In conclusion, a 12-week weight loss intervention did not result in increased bone 
loss in overweight and obese postpartum women. While there were no significant 
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changes in CRP between groups, decreases in CRP predicted an increase in total body 
BMD, while an increase in cardiovascular fitness predicted an increase in femoral neck 
BMD, suggesting that the addition of aerobic exercise to a weight loss regimen may 
attenuate bone loss observed with weight loss and lactation.
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CHAPTER VI 
EPILOGUE 
 The research presented in this dissertation utilized practical, time and labor-saving 
strategies for reducing weight retention in postpartum women. It used technology-based 
tools, such as online diet tracking and regular follow up with an RD by email or phone. 
Additionally, it was one of few studies to examine the impact of weight loss on MetSyn, 
cardiometabolic risk factors, and inflammation in this population. Finally, it was the first 
to our knowledge to examine the relationship between systemic inflammation and BMD 
after weight loss in postpartum women.  
 The results of the first study suggest that a home-based diet and exercise 
intervention that utilized self-monitoring of lifestyle behaviors and individualized 
recommendations from a registered dietitian is an effective strategy for reducing weight 
and abdominal obesity in postpartum women. It was also successful in promoting 
improvements in cardiovascular fitness, which may have been responsible for the 
increased weight loss observed in the intervention group. The results from the second 
study suggest that a weight loss intervention may reduce some cardiometabolic risk 
factors, and reduce the prevalence of MetSyn in this population. Finally, the third study 
suggests that aerobic exercise contributes to an attenuation of bone loss during weight 
loss in postpartum women.  
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 One of the biggest challenges faced for this research study was participant 
recruitment. We utilized a variety of strategies to recruit, including posting flyers in local 
obstetrician and pediatrician offices, churches, infant stores, day care facilities, at local 
mothers groups, and on Facebook. We also recruited in person at the Women’s Hospital 
prenatal birth and breastfeeding classes, breastfeeding support groups, and pre- and 
postnatal yoga classes. We attempted to recruit through local lactation consultants, but 
struggled to maintain contact with them. The most successful method was in-person 
recruitment at the hospital classes. This is a very specific population with time constraints 
unique to them. While many women may have liked the concept of an intervention to 
help them lose the baby weight, the practicality of following a diet and exercise 
intervention may have been too time consuming while also caring for a new infant. 
Several women allocated to the control group even mentioned after the study completed 
that they were happy to have been randomized to the control group, as they did not 
believe they would have had the time to follow the intervention.  
 Another problem was that many women who screened were eligible, but declined 
participation in the study for reasons including lack of time, returning to work, or not 
wanting to be assigned to the control group. Changing the eligibility to allow women to 
participate at 6 weeks postpartum seemed to be an effective way to recruit women, as it 
allowed us to enroll participants before they returned to work. Additionally, several 
women who were interested in participating were ineligible to participate due to having a 
BMI greater than 35 kg/m2. These are the women who would most benefit from a weight 
loss intervention. However, the reason they were excluded was because obese 
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participants tend to drop out of studies more frequently. They also tend to struggle to lose 
weight during an intervention, which may have impacted the results of the second study. 
It was difficult to tell a woman that her BMI was too high to participate in a weight loss 
intervention, and an attempt was made to find other reasoning for ineligibility. Strategies 
that effectively help obese women lose weight are needed.  
 Another problem we encountered was that we did not have enough power to 
detect significant differences in cardiometabolic risk factors and inflammation. This 
intervention was designed to test practical strategies for weight loss in postpartum 
women, so actual weight loss that was observed was modest relative to other studies. This 
may not have been adequate to cause significant change in these variables over the 12-
week time frame. A longer duration intervention targeted toward a specific amount of 
weight loss may have better results.  
 One outcome that was noted was that it seemed that the women who had the 
greatest success with the intervention were already highly motivated individuals, who had 
relatively healthy lifestyles prior to pregnancy. They just required some extra guidance 
and something to keep them accountable (regular contact with the RD, diet tracking, 
pedometer) to help them achieve their goals. Other participants who had poorer diet 
quality and lower physical activity prior to pregnancy struggled more to lose weight. 
However, those women were the ones that commented the most on how they were 
unaware of how many calories they were eating or how sedentary their lifestyle was. 
Habits formed over many years are difficult to change, but I believe that the intervention 
helped many of these women to become more aware of their habits and start to make 
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changes they can maintain. For these women, setting lower, more achievable weight loss 
goals may be beneficial.  
 There are several areas of future research that I would like to explore. The first is 
to design a weight loss intervention tailored toward specific, individualized weight loss 
goals. The National Institute of Health Body Weight Planner is a new tool available that 
more accurately estimates the energy intake required to lose a desired amount of weight 
over a specific time period. A research study utilizing this tool will allow for more 
individualized calorie prescription to be provided to research participants.  
 The second area of research is to determine the effect of different dietary 
components on inflammation and MetSyn. I am planning to use the data from this study 
to examine the relationship between diet quality and anti-inflammatory food components 
(omega-3 fatty acids, monounsaturated fats, glycemic index) with inflammation and 
cardiometabolic risk factors. In the future, I would like to conduct a research study to 
determine the effects of a Mediterranean-style diet on inflammation and cardiometabolic 
risk factors in postpartum women.  
 Finally, I would like to further explore the relationship between aerobic fitness 
and inflammation. This would first involve conducting an observational study comparing 
weight-matched sedentary individuals to individuals with varying degrees of physical 
activity. This would be followed up by designing a randomized, intervention of 
overweight and obese individuals with a more tailored aerobic exercise regimen.  
 This study was designed to promote weight loss in postpartum women and reduce 
cardiometabolic risk factors, and was successful in reducing weight and abdominal 
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obesity, while improving cardiovascular fitness. We were also successful in improving 
insulin resistance and triglycerides in this population. The process of conducting this 
study was rewarding, especially hearing positive comments from participants how it 
helped them achieve their goals to live a healthier life. This research was successful 
thanks to the women who participated in the study, the research staff who assisted with 
recruitment and laboratory visits, and the Women’s Hospital for being a main source of 
recruitment. I am excited to further examine the data from this study, and to continue my 
research working to improve the health of postpartum women 
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APPENDIX A 
BIVARIATE CORRELATIONS TABLES
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Table A.1. Baseline Correlations between Body Composition, Cardiovascular 
Fitness, and Inflammation with BMD. 
 TB BMD 
(g/cm2) 
LS BMD 
 (g/cm2) 
Hip BMD 
(g/cm2) 
FN BMD 
(g/cm2) 
Age (yr) 0.025 -0.051 -0.022 -0.159 
Weight (kg) 0.292 0.230 -0.001 -0.004 
BMI (kg/m2) 0.243 0.064 0.018 -0.121 
Fat mass (kg) 0.090 -0.008 -0.223 -0.221 
Lean mass (kg) 0.446a 0.476b 0.328d 0.326d 
VO2 max (mL/kg/min) 0.224 0.306 0.362
d 0.349d 
hs-CRP (mg/L) -0.086 -0.333d -0.190 -0.201 
Calcium intake (mg) 0.234 0.285 0.217 0.162 
Lactation score 
percentage 
0.245 0.272 0.433a 0.342d 
Pearson’s correlation coefficients 
BMD, bone mineral density; TB, total body; LS, lumbar spine; Hip, total hip; FN, 
femoral neck; BMI, body mass index; hs-CRP, high sensitivity C-reactive protein 
a p < 0.05, b p <0.01, c p <0.001, d p <0.09
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Table A.2. Baseline Correlations between Body Composition, Cardiovascular 
Fitness, and Inflammation with BMC.  
 TB BMC  
(g) 
LS BMC  
(g) 
Hip BMC  
(g) 
FN BMC  
(g) 
Age (yr) -0.001 0.080 0.090 0.092 
Weight (kg) 0.469b 0.279 0.155 0.222 
BMI (kg/m2) 0.244 -0.052 -0.041 -0.004 
Fat mass (kg) 0.247 -0.044 -0.153 -0.036 
Lean mass (kg) 0.595c 0.685c 0.580c 0.542b 
VO2 max (mL/kg/min) 0.192 0.197 0.449
b 0.359d 
hs-CRP (mg/L) -0.020 -0.289 -0.179 -0.204 
Calcium intake (mg) 0.254 0.257 0.219 0.224 
Lactation score 
percentage 
0.267 0.221 0.309 0.180 
Pearson’s correlation coefficients 
BMC, bone mineral content; TB, total body; LS, lumbar spine; Hip, total hip; FN, 
femoral neck; BMI, body mass index; hs-CRP, high sensitivity C-reactive protein 
a p < 0.05, b p <0.01, c p <0.001, d p <0.09
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Table A.3. Endpoint Correlations between Body Composition, Cardiovascular 
Fitness, and Inflammation with BMD. 
 TB BMD  
(g/cm2) 
LS BMD  
(g/cm2) 
Hip BMD  
(g/cm2) 
FN BMD  
(g/cm2) 
Age (yr) 0.039 -0.001 0.074 -0.039 
Weight (kg) 0.326d 0.216 0.010 -0.097 
BMI (kg/m2) 0.288 0.132 0.006 -0.215 
Fat mass (kg) 0.162 0.071 -0.200 -0.304d 
Lean mass (kg) 0.427a 0.333d 0.343d 0.283 
VO2 max (L/min) 0.108 0.015 0.239 0.331
d 
hs-CRP (mg/L) 0.0001 -0.158 -0.197 -0.336d 
Calcium intake (mg) 0.272 0.193 0.152 -0.038 
Lactation score 
percentage 
0.002 0.019 0.264 0.312 
Pearson’s correlation coefficients 
BMD, bone mineral density; TB, total body; LS, lumbar spine; Hip, total hip; FN, 
femoral neck; BMI, body mass index; hs-CRP, high sensitivity C-reactive protein 
a p < 0.05, b p <0.01, c p <0.001, d p <0.09
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Table A.4. Endpoint Correlations between Body Composition, Cardiovascular 
Fitness, and Inflammation with BMC 
 TB BMC  
(g) 
LS BMC  
(g) 
Hip BMC  
(g) 
FN BMC  
(g) 
Age (yr) -0.110 0.068 0.122 -0.012 
Weight (kg) 0.449b 0.331d 0.162 0.156 
BMI (kg/m2) 0.230 0.079 -0.025 -0.067 
Fat mass (kg) 0.247 0.101 -0.150 -0.113 
Lean mass (kg) 0.555c 0.550c 0.610c 0.533b 
VO2 max (L/min) 0.143 0.096 0.377
a 0.365a 
hs-CRP (mg/L) -0.116 -0.093 -0.309 -0.396a 
Calcium intake (mg) 0.310d 0.282 0.205 0.041 
Lactation score 
percentage 
-0.005 -0.006 0.281 0.185 
Pearson’s correlation coefficients 
BMC, bone mineral content; TB, total body; LS, lumbar spine; Hip, total hip; FN, 
femoral neck; BMI, body mass index; hs-CRP, high sensitivity C-reactive protein 
a p < 0.05, b p <0.01, c p <0.001, d p <0.09
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Table A.5. Correlations between Change in Body Composition, Cardiovascular 
Fitness, and Inflammation and Change in BMD. 
 Δ TB BMD 
(g/cm2) 
Δ LS BMD 
(g/cm2) 
Δ Hip BMD 
(g/cm2) 
Δ FN BMD 
(g/cm2) 
Δ Weight (kg) 0.167 0.040 0.164 -0.085 
Δ BMI (kg/m2) 0.128 0.076 0.197 -0.045 
Δ Fat mass (kg) 0.060 0.152 0.209 0.024 
Δ Lean mass (kg) 0.301d -0.254 -0.121 -0.306d 
Δ VO2 max (L/min) -0.044 -0.273 0.224 0.314
d 
Δ hs-CRP (mg/L) -0.358d -0.078 -0.162 -0.172 
4 day calcium average (mg) -0.315d -0.039 -0.088 -0.061 
Endpoint lactation score % -0.473a -0.383d -0.492b -0.222 
Pearson’s correlation coefficients 
BMD, bone mineral density; TB, total body; LS, lumbar spine; Hip, total hip; FN, 
femoral neck; BMI, body mass index; hs-CRP, high sensitivity C-reactive protein 
a p < 0.05, b p <0.01, c p <0.001, d p <0.09
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Table A.6. Correlations between Change in Body Composition, Cardiovascular 
Fitness, and Inflammation and Change in BMC. 
 Δ TB BMC  
(g) 
Δ LS BMC  
(g) 
Δ Hip BMC  
(g) 
Δ FN BMC  
(g) 
Δ Weight (kg) 0.139 0.224 0.174 0.046 
Δ BMI (kg/m2) 0.143 0.200 0.209 0.059 
Δ Fat mass (kg) 0.356a 0.239 0.229 0.085 
Δ Lean mass (kg) -0.589c -0.021 -0.132 -0.116 
Δ VO2 max (L/min) 0.017 0.207 0.181 0.313
d 
Δ hs-CRP (mg/L) -0.127 -0.152 -0.201 -0.095 
4 day calcium average (mg) -0.064 0.070 -0.153 -0.040 
Endpoint lactation score % -0.486b -0.418a -0.513b -0.321 
Pearson’s correlation coefficients 
BMC, bone mineral content; TB, total body; LS, lumbar spine; Hip, total hip; FN, 
femoral neck; BMI, body mass index; hs-CRP, high sensitivity C-reactive protein 
a p < 0.05, b p <0.01, c p <0.001, d p <0.09
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APPENDIX B 
STUDY FORMS
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UNIVERSITY OF NORTH CAROLINA AT GREENSBORO 
 
Project Title:  Get Active and Eat Right: Moms at Work 
 
Project Director:  Cheryl Lovelady and Elyse Shearer 
 
Participant's Name:  ______________________________________ 
 
What is the study about?  
This is a research project studying the effects of a diet and exercise program on weight 
loss in postpartum women. 
 
Why are you asking me? 
We are recruiting women 18 years and older who are pregnant or up to 14 weeks 
postpartum. Women must be overweight or are at least 10 pounds heavier than they were 
before they were pregnant. Participants must be free of chronic disease and nonsmokers. 
Participants who have had a C-section will be eligible to participate at 14 weeks 
postpartum. 
 
What will you ask me to do if I agree to be in the study? 
This study will begin ten to fourteen weeks after you deliver your baby and will continue 
for twelve weeks. If you consent to participate, your baseline measurement will be done 
at 10 to 14 weeks postpartum. Upon completion of the baseline measurement (described 
below), you will be assigned by chance to one of two groups. The intervention group will 
participate in the 12 week reduced calorie diet and exercise program. If you are assigned 
to the control group, you will be asked not to change your diet or exercise habits until the 
end measurements. Upon completion of the second set of measurement, at 22 to 26 weeks 
postpartum, the control group will be given all the dietary intervention materials, as well 
as a consultation with the registered dietitian.  
 
Participants in both groups will be asked to do the following: 
1. Receive medical clearance from your physician, through the form provided, to 
participate in the diet and exercise program.  
2. Participate in two short dietary recall sessions. You will be called two times in 
one week at your convenience at the beginning (10 to 14 weeks postpartum) and 
at the end of the intervention (22 to 26 weeks postpartum. This diet record will be 
used to determine your nutritional intake and develop a reduced calorie diet for 
the intervention group.  
3. Visit the Human Nutrition Laboratory at UNCG for several measurements at the 
beginning and end of the study. This visit should take approximately 2 hours, 
including the DXA scan and BOD POD analysis.  
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a. You will be asked to provide a total of 2 tablespoons of venous blood per 
laboratory measurement. The blood will be drawn in the morning at the 
lab after an overnight fast (no alcohol for 24 hours prior to blood draw). 
Venipuncture will be performed by a trained phlebotomist. The blood is 
need to assess your blood sugar, lipids (cholesterol, triglycerides), insulin, 
and markers of inflammation and metabolism.  
b. Your height and weight will be recorded followed by resting heart rate, 
blood pressure, and waist and hip circumference.  
c. Your cardiovascular fitness will be measured through an exercise test on a 
treadmill. You will walk or run on the treadmill, beginning at a low level, 
and will increase until you reach 85% of your calculated maximum heart 
rate. A researcher certified in cardiopulmonary resuscitation (CPR) will be 
present at the exercise session. Heart rate and rating of how hard you think 
you are working will be measured throughout the test.  
d. Your body composition will be measured BOD POD analysis. You will be 
asked to wear form-fitting clothes, such as a swim suit, and a swim cap. 
You may wear your own swim suit or one will be provided to you by the 
research staff. You will sit quietly in the BOD POD. You may hear 
clicking sounds or the hum of a fan during the procedure. You will not 
feel any changes in pressure. The measurement will take about 5 minutes.  
e. Finally, you will be given a body scan by dual energy x-ray 
absorptiometry (DXA). This whole-body scan is necessary to determine 
your bone density. You will lay still and flat on an x-ray table, and the 
scanner will move back and forth several feet above you. The entire 
procedure takes approximately 30 minutes depending on your height.  
f. You will be given a pregnancy test to ensure that you are not pregnant 
before the DXA scan is administered.  
 
Those assigned by chance to the intervention group will also be asked to do the 
following: 
1. Follow a reduced calorie diet prescribed by the Registered Dietitian (RD) at your 
initial meeting. You will be asked to track your diet three days per week for 12 
weeks using the USDA MyPlate SuperTracker, found online. This record will be 
accessed by the RD in order to provide you with diet recommendations, as well as 
to ensure compliance with the reduced calorie diet. Diet recommendations will be 
sent to you by email. 
2. You will be given an exercise prescription, and encouraged to walk briskly with a 
pedometer (provided to you) or perform other exercises every day. You will be 
asked to record the number of steps and other physical activity in a log book, 
which will be provided.   
3. You will be required to meet with the research staff at the Human Nutrition 
Laboratory after 6 weeks, where we will measure your weight, waist and hip 
circumference. This meeting should take about 15 minutes.  
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4. You will be asked to measure your weight, waist, and hip circumference weekly 
and text or email these measurements, as well as daily steps, to the research staff 
every week. 
5. You will be encouraged to breastfeed your baby and provided with support and 
resources for pumping breast milk at work.  
 
What are the dangers to me? 
The Institutional Review Board at the University of North Carolina at Greensboro has 
determined that participation in this study poses minimal risk to participants. However, 
there is a risk of injury during exercise for you. Temporary muscle fatigue and/or 
respiratory discomfort may result from the graded exercise test. Weekly exercise may 
result in temporary muscle soreness. Insertion of the needle during the blood draw may 
be slightly painful. Every precaution will be taken to minimize the risks involved with 
venipuncture (air emboli, infection, bruising, and fainting). You will be exposed to very 
mild radiation from the DXA scan, equivalent to 1/10 the exposure from a routine chest 
x-ray, and less than the exposure of a dental x-ray. The University has no policy or plan 
to pay for any injuries you might receive as a result of participating in this research 
protocol.  
 
If you have any concerns about your rights, how you are being treated or if you have 
questions, want more information or have suggestions, please contact the Office of Research 
Compliance at UNCG toll-free at (855)-251-2351. 
Questions, concerns or complaints about this project or benefits or risks associated with 
being in this study can be answered by Dr. Cheryl Lovelady who may be contacted at 
(336-256-0310). 
 
Are there any benefits to society as a result of me taking part in this research? 
The results of this study may be used to improve weight loss in overweight postpartum 
women and prevent obesity and chronic disease later in life. Strategies tested in this study 
may be used to promote weight loss for postpartum mothers across the country in order to 
reduce healthcare costs. 
 
Are there any benefits to me for taking part in this research study? 
Results of all the tests conducted will be provided to you at no cost. All mothers 
participating in the study will undergo two free bone density scans and two BOD POD 
analyses, which provide valuable bone density and body composition information. 
Women in the control group will receive a free consultation with the RD at the end of the 
study. Benefits to the intervention participants include the potential for weight loss and 
increased cardiovascular fitness.  
 
Will I get paid for being in the study?  Will it cost me anything? 
There are no costs to you or payments made for participating in this study. 
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How will you keep my information confidential? 
All information obtained in this study is strictly confidential unless disclosure is required 
by law. All information will be stored in a locked file cabinet in the Human Nutrition 
Lab; only the researchers will have access to the records. Any report of this research that 
is made available to the public will not include your name or any other individual 
information by which you could be identified.  
  
What if I want to leave the study? 
You have the right to refuse to participate or to withdraw at any time, without penalty.  If 
you do withdraw, it will not affect you in any way.  If you choose to withdraw, you may 
request that any of your data which has been collected be destroyed unless it is in a de-
identifiable state. 
 
What about new information/changes in the study?  
If significant new information relating to the study becomes available which may relate 
to your willingness to continue to participate, this information will be provided to you. 
 
Voluntary Consent by Participant: 
By signing this consent form you are agreeing that you read, or it has been read to you, 
and you fully understand the contents of this document and are openly willing consent to 
take part in this study.  All of your questions concerning this study have been answered. 
By signing this form, you are agreeing that you are 18 years of age or older and are 
agreeing to participate, or have the individual specified above as a participant participate, 
in this study described to you by _____________________________________________.  
 
 
 
Signature: _________________________________________ Date: ________________
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Get Fit and Lose Weight After You Have Your Baby 
 
 Are you Pregnant or Have a New Baby? 
 Did you Gain Too Much Weight During Your Pregnancy? 
 Do you Want to Get In Shape and Lose the Pregnancy Weight? 
 Are you Interested in Participating in an Exercise and Weight Loss 
Program? 
 
If YES to All Then GIVE US A CALL! 
 
The purpose of this research is to investigate the effects of a diet and exercise 
program on weight loss in postpartum women.  
 
Who is eligible? 
 Women who are pregnant or have a baby less than 14 weeks old 
 18 years or older 
 Overweight or are at least 10 pounds heavier than before pregnancy 
 Nonsmokers 
 Free of chronic disease 
 English speaking 
 
All eligible women in the study receive a bone density scan, body composition analysis, exercise 
testing, and blood analysis 2 times during the study. Some women in the study may be enrolled 
in a 12-week intervention which includes dietary modifications and exercise instruction under the 
supervision of a registered dietitian.  Women not enrolled in the intervention will receive a free 
consultation with the registered dietitian at the completion of the study. 
 
The initial and follow up measurements take approximately 2 hours. If enrolled in the 
intervention, you will meet with the research staff 2 times over 12 weeks for 15 minutes. 
Participants will be asked to monitor their diet and exercise weekly. Times will vary for each 
participant.  
 
For More Information, please contact: 
Dr. Cheryl Lovelady or Elyse Shearer 
at 336.256.1090 or email e_sheare@uncg.edu 
 
University of North Carolina at Greensboro 
Human Nutrition Laboratory
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Research Study:  Get Active, Eat Right, Mom’s at Work      
First Contact Date:______________________ 
Screening Form 
 
Name _______________________ Age__________________________ 
 
Phone Number_______________ Number of Children____________ 
        
Address ___________________________________________________________ 
 
Are you currently pregnant?___________ 
  
Weeks Pregnant______________ Due Date for Infant______________ 
 
Plan to breastfeed?_____________________________________________ 
 
If not pregnant, when is baby’s birthdate?_________________________ 
 
C-section?___________    Delivery/Pregnancy Complications?_________ 
 
Full term infant?____________ Singleton birth?___________  
 
Weight after delivery_______     Weight gain?_______  Breastfeeding?____________ 
 
Pre-pregnancy Weight __________   Current Weight________________ 
 
Current Height_____ft_____in   Smoker?______________________ 
 
Agrees to random assignment?______ Returning to work/school?_______ 
 
Chronic diseases? (DM, HTN, CVD, asthma, bone/joint problems) _________ 
__________________________________________________________________ 
 Medications?______________________________________________________ 
 
 
BMI (prepregnant):________ 
Comments:______________________________________________________________
_______________________________________________________________________
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Participant Questionnaire 
 
1. My ethnicity is:  
 
_____ Asian or Asian American, including Chinese, Japanese, and others  
_____ Black or African American  
_____ Hispanic or Latino, including Mexican American, Central American, and others  
_____ White, Caucasian, Anglo, European American; not Hispanic  
 _____American Indian/Native American  
_____ Other (write in):  
 
2. What is the highest level of education you have completed? 
 
_____ Graduate degree 
_____ Some graduate school 
_____ College degree 
_____ Some college 
_____ High school  
_____ Some high school 
 
3. My marital status is:  
 
_____ Single  
_____ Married  
_____ Separated or divorced  
_____ Widowed  
_____ Other  
 
4. What is your total household income? 
 
_____ Less than $20,000 
_____ $20,000 to $30,000  
_____ $30,000 to $39,999 
_____ $40,000 to $49,999 
_____ $50,000 to $59,999 
_____ More than $60,000 
 
5. Do you work or plan on returning to work? 
 
_____ Yes 
_____ No 
 
6. If you answered yes to Question 5, what is your occupation? 
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7. How many hours do you usually work each week? 
 
_____ Less than 20 hours/week 
_____ 20-30 hours/week 
_____ 31-40 hours/week 
_____ More than 40 hours/week 
 
8. What is your activity level at work? 
 
_____ Sitting 
_____ Standing – Light work 
_____ Standing – Moderate work 
_____ Standing – Heavy work 
_____ Walking 
_____ Lifting 
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Perceived Stress Scale 
 
The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate by circling how often you felt or 
thought a certain way. 
 
0 = Never 1 = Almost Never 2 = Sometimes 3 = Fairly Often 4 = Very Often 
 
1. In the last month, how often have you been upset 
    because of something that happened unexpectedly?..................... 0     1     2     3      4 
 
2. In the last month, how often have you felt that you were unable 
    to control the important things in your life?...................................... 0     1     2     3      4 
 
3. In the last month, how often have you felt nervous and  
    “stressed”?....................................................................................... 0     1     2     3      4 
 
4. In the last month, how often have you felt confident about your ability 
    to handle your personal problems?................................................. 0     1     2     3      4 
 
5. In the last month, how often have you felt that things   
    were going your way?...................................................................... 0     1     2     3      4 
 
6. In the last month, how often have you found that you could not cope 
    with all the things that you had to do? ............................................ 0     1     2     3      4 
 
7. In the last month, how often have you been able 
    to control irritations in your life?...................................................... 0     1     2     3      4 
 
8. In the last month, how often have you felt that you were on top of  
    things?............................................................................................. 0     1     2     3      4 
 
9. In the last month, how often have you been angered 
    because of things that were outside of your control? ..................... 0     1     2     3      4 
 
10. In the last month, how often have you felt difficulties 
      were piling up so high that you could not overcome them?........... 0     1     2     3      4 
